Study ID	Patient ID	Sample ID	Age	Age at Which Sequencing was Reported (Years)	Albumin	ALK driver	ALK protein change	Archer Panel	ARID1A driver	ARID1A protein change	BOR	BRAF driver	BRAF protein change	Cancer Type	Cancer Type Detailed	Clinically reported PD-L1 score	CRDB_SURVEY_COMMENTS	CT scan type	Impact TMB Percentile (Across All Tumor Types)	Impact TMB Score	Impact TMB Percentile (Within Tumor Type)	Cytology fixation type	Date added to cBioPortal	Durable clinical response	Date of death	Disease	dNLR	Date of last drug administration	Drug start date	ECOG	EGFR driver	EGFR protein change	ERBB2 driver	ERBB2 protein change	Date of Last Contact	Fraction Genome Altered	Gene Panel	Halo tumor quality score	Histology	Was IMPACT done on the same tissue that PD-L1 IHC was done on?	Institute Source	IO drug name	Line of therapy	JS PD-L1 score	Manual tumor annotation	Metastatic Site	MET driver	MET protein change	MGMT Status	Monotherapy vs. Combination	Month added to cBioPortal	MSI Comment	MSI Score	MSI Type	MSK Slide ID	Mutation Count	Oncotree Code	Overall survival	Other Patient ID	Pack-year history	MSK Pathology Slide Available	PD-L1 tissue site	PFS date	PFS Months	PFS Status	Primary Tumor Site	Clinical trial IRB	RET driver	RET protein change	ROS1 driver	ROS1 protein change	Sample Class	Number of Samples Per Patient	Sample coverage	Sample Type	Sex	What is the patient's smoking status?	Somatic Status	SO comments	Status	STK11 driver	STK11 protein change	TMB	Tumor Purity	Treatment Setting	Is the patient deceased?	Week added to cBioPortal	WHO Grade
lung_msk_mind_2020	P-0000239	P-0000239-T01-IM3	83	82	3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	58.6	4.5	42.2	NA	4/7/15	NA	30647	NSCLC	3.3	30624	30582	1	FALSE	NA	FALSE	NA	30647	0.0020	IMPACT341	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	NA	NA	NA	FALSE	NA	NA	PD1 alone	2015/04	NA	0	Stable	NA	4	LUAD	2.1	DMP0217	28	NO	lung	30636	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	970	Primary	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	4.5	30	SOC	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0000302	P-0000302-T01-IM3	67	66	4	FALSE	NA	NO	FALSE	NA	PR	TRUE	G469A (driver)	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest	17.3	1.1	11.2	NA	4/7/15	NA	NA	NSCLC	3.6	25774	24723	2	FALSE	NA	FALSE	NA	25774	0.0000	IMPACT341	NA	Adenocarcinoma	No	MSKCC	Nivolumab	3	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2015/04	NA	0.1	Stable	NA	1	LUSC	NA	NA	28	NO	lung	25717	32.7	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	739	Metastasis	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	1.1	30	SOC	No	2015, Wk. 15	NA
lung_msk_mind_2020	P-0001987	P-0001987-T01-IM3	57	55	4.3	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen	95.8	26.8	96.7	NA	4/7/15	NA	NA	NSCLC	2	21532	20824	1	FALSE	NA	FALSE	NA	21532	0.4290	IMPACT341	80	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	80	Yes	Brain	FALSE	NA	NA	PD1 alone	2015/04	NA	0.73	Stable	NA	24	LUAD	NA	DMP1921	33	NO	brain	21322	16.4	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	465	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	26.8	30	SOC	No	2015, Wk. 15	NA
lung_msk_mind_2020	P-0002485	P-0002485-T01-IM3	43	45	4.7	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	43	3.3	29.4	NA	4/7/15	Durable clinical benefit	16663	NSCLC	2.4	16135	15925	1	FALSE	NA	FALSE	NA	16663	0.0331	IMPACT341	95	Squamous	No	MSKCC	Durvalumab	1	5	No	NA	FALSE	NA	NA	PD1 alone	2015/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	3	LUSC	24.2	NA	10	NO	lung	16150	7.4	1:PROGRESS	Lung	12-179	FALSE	NA	FALSE	NA	Tumor	1	608	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	3.3	NA	Clinical trial	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0002794	P-0002794-T01-IM3	61	61	4.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	70	NA	CT chest/abdomen/pelvis	17.1	1.1	11.2	NA	4/7/15	NA	NA	NSCLC	3.3	23830	22504	2	FALSE	NA	FALSE	NA	23842	0.0001	IMPACT341	70	Adenocarcinoma	No	MSKCC	Nivolumab	2	70	No	Bone	FALSE	NA	NA	PD1 alone	2015/04	NA	-1	Do not report	NA	1	LUAD	NA	NA	5	NO	lung	22955	14.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	213	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Unmatched	NA	Included	FALSE	NA	1.1	20	SOC	No	2015, Wk. 15	NA
lung_msk_mind_2020	P-0002921	P-0002921-T01-IM3	73	73	3.5	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	91.7	14.5	87.6	NA	4/7/15	Durable clinical benefit	27279	NSCLC	2.5	27069	26918	1	FALSE	NA	FALSE	NA	27279	0.0838	IMPACT341	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2015/04	NA	0.72	Stable	961122	13	LUAD	11.9	NA	20	YES	lung	27117	6.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	438	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	14.5	30	SOC	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0003247	P-0003247-T01-IM5	76	73	2.8	FALSE	NA	NO	FALSE	NA	CR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	20	NA	CT chest	79.1	7.9	63.8	NA	4/7/15	NA	NA	NSCLC	3.6	28327	27894	0	FALSE	NA	FALSE	NA	28350	0.0490	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	70	No	RUQ	FALSE	NA	NA	PD1 alone	2015/04	NA	0.09	Stable	NA	8	LUAD	NA	NA	24	NO	pelvis	28276	12.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	597	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	7.9	20	SOC	No	2015, Wk. 15	NA
lung_msk_mind_2020	P-0003250	P-0003250-T01-IM5	54	53	3.5	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	49.7	3.9	34.6	NA	4/7/15	No durable clinical benefit	NA	NSCLC	2.8	20055	20032	1	TRUE	L858R (driver)	FALSE	NA	20217	0.4928	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Pembrolizumab	3	0	No	NA	FALSE	NA	NA	PD1 alone	2015/04	NA	0.56	Stable	NA	4	LUAD	NA	NA	0	NO	lung	20060	0.9	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	572	Primary	Female	Never smoker	Matched	NA	Included	FALSE	NA	3.9	50	SOC	No	2015, Wk. 15	NA
lung_msk_mind_2020	P-0003275	P-0003275-T01-IM5	69	69	4.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	37.9	3	25.7	NA	4/7/15	No durable clinical benefit	25908	NSCLC	3	25571	25402	1	FALSE	NA	FALSE	NA	25908	0.0021	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2015/04	NA	0	Stable	NA	3	LUAD	16.6	NA	20	NO	lung	25568	5.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	689	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	3	20	SOC	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0003551	P-0003551-T02-IM6	50	51	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	89.2	11.4	81.4	NA	9/28/17	NA	NA	NSCLC	1.7	18531	18503	1	TRUE	AMP (driver), L858R (driver)	FALSE	NA	19146	0.5334	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	10	No	NA	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	4.17	Indeterminate	694578	13	LUAD	NA	NA	0	YES	lung	18542	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	801	Primary	Female	Never smoker	Matched	NA	Included	FALSE	NA	11.4	30	SOC	No	2017, Wk. 39	NA
lung_msk_mind_2020	P-0003635	P-0003635-T01-IM5	58	57	4.2	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	74.4	6.9	57.5	NA	4/7/15	NA	21513	NSCLC	3.1	21481	21439	2	TRUE	E746_A750del (driver)	FALSE	NA	21513	0.6668	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Ipilimumab+Nivolumab	3	NA	NA	Brain	FALSE	NA	NA	PD1+CTLA4	2015/04	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.8	Indeterminate	NA	7	LUAD	2.4	NA	0	NO	lung	21486	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	667	Metastasis	Female	Never smoker	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 20q        Note: Copy number profile is suggestive of a fragmented genome..        Note: The SRC, TOP1, PTPRT, and NCOA3 copy number gain falls slightly below the cut off 	Excluded	FALSE	NA	6.9	50	SOC	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0003735	P-0003735-T01-IM5	68	67	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	13.1	1	7.8	NA	4/7/15	NA	25136	NSCLC	2.8	25034	25034	1	FALSE	NA	FALSE	NA	25136	0.0073	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	4	0	No	Pleura	TRUE	X963_splice (driver)	NA	PD1 alone	2015/04	NA	0.08	Stable	NA	1	LUAD	3.3	NA	2.5	NO	pleura	25060	0.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	429	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	1	NA	SOC	Yes	2015, Wk. 15	NA
lung_msk_mind_2020	P-0004271	P-0004271-T01-IM5	38	36	4.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	10	NA	CT chest/abdomen/pelvis	37.9	3	25.7	NA	5/6/15	Durable clinical benefit	NA	NSCLC	1	14386	14176	0	FALSE	NA	FALSE	NA	14557	0.0496	IMPACT410	95	Adenocarcinoma	No	MSKCC	Atezolizumab	1	10	No	NA	FALSE	NA	NA	PD1 alone	2015/05	NA	0.16	Stable	NA	3	LUAD	NA	NA	0	NO	lung	14393	7.1	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	422	Primary	Female	Never smoker	Matched	NA	Included	FALSE	NA	3	60	SOC	No	2015, Wk. 19	NA
lung_msk_mind_2020	P-0004395	P-0004395-T01-IM5	65	65	4.1	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	5/28/15	NA	24070	NSCLC	1.5	24058	24058	1	FALSE	NA	TRUE	S310F (driver)	24070	0.5828	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	6	0	No	Brain	FALSE	NA	NA	PD1 alone	2015/05	NA	1.84	Stable	NA	8	LUAD	0.4	NA	89.25	NO	brain	24070	0.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	510	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: The ERBB3 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	Included	FALSE	L286R	7.9	50	SOC	Yes	2015, Wk. 22	NA
lung_msk_mind_2020	P-0004476	P-0004476-T01-IM5	67	68	3.4	FALSE	P1456H	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest/abdomen/pelvis	74.4	6.9	57.5	NA	5/28/15	NA	25163	NSCLC	2.4	24557	24529	1	FALSE	NA	FALSE	NA	25163	0.3254	IMPACT410	95	Adenocarcinoma	No	MSKCC	Resection + Nivolumab	1	5	No	Lymph Node	FALSE	NA	NA	PD1 alone	2015/05	NA	2.39	Stable	1142806	7	LUAD	20.8	NA	20	YES	pleura	24569	1.3	1:PROGRESS	Lung	14-137	FALSE	NA	FALSE	NA	Tumor	1	301	Metastasis	Female	Former smoker	Matched	Note: The MRE11A exon 4 mutations all occur in cis (same allele).	Included	FALSE	NA	6.9	50	Clinical trial	Yes	2015, Wk. 22	NA
lung_msk_mind_2020	P-0004588	P-0004588-T01-IM5	73	74	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen	49.7	3.9	34.6	NA	6/3/15	NA	NA	NSCLC	1.7	28267	26769	1	FALSE	NA	FALSE	NA	28267	0.0035	IMPACT410	95	Adenocarcinoma	No	MSKCC	Nivolumab	3	95	No	NA	FALSE	NA	NA	PD1 alone	2015/06	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1142804	4	LUAD	NA	NA	33.75	YES	liver	28263	49.1	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	756	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	3.9	10	SOC	No	2015, Wk. 23	NA
lung_msk_mind_2020	P-0005783	P-0005783-T02-IM6	53	55	4.1	FALSE	L63I	YES	FALSE	Q1552H	CR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest	99.4	90.4	100	NA	10/7/17	NA	NA	NSCLC	2.3	19949	19585	0	FALSE	NA	FALSE	NA	20375	0.6344	IMPACT468	80	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	0	No	Brain	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.09	Indeterminate	721812	102	LUAD	NA	NA	10	YES	brain	20280	22.8	0:CENSORED	Lung	NA	FALSE	AMP, S829I	FALSE	K1422N	Tumor	1	603	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	90.4	30	SOC	No	2017, Wk. 40	NA
lung_msk_mind_2020	P-0005871	P-0005871-T01-IM5	47	48	4.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	3	25.7	NA	8/6/15	No durable clinical benefit	18056	NSCLC	2.4	17423	17264	1	FALSE	NA	TRUE	V659E (driver)	18056	0.2834	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Resection + Nivolumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2015/08	NA	0.46	Stable	NA	3	LUAD	26	NA	0	NO	lung	17434	5.6	1:PROGRESS	Lung	14-137	FALSE	NA	FALSE	NA	Tumor	1	713	Primary	Male	Never smoker	Matched	NA	Excluded	FALSE	NA	3	70	Clinical trial	Yes	2015, Wk. 32	NA
lung_msk_mind_2020	P-0006046	P-0006046-T01-IM5	60	60	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	I572F	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen	94.4	20.7	94.1	Cytolyt	8/18/15	NA	NA	NSCLC	3.1	22753	22011	1	FALSE	NA	FALSE	NA	23040	0.2782	IMPACT410	95	Adenocarcinoma	No	MSKCC	Nivolumab	3	0	No	NA	FALSE	NA	NA	PD1 alone	2015/08	NA	0.31	Stable	NA	21	LUAD	NA	NA	40	NO	lymph node	22946	30.7	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	716	Primary	Male	Former smoker	Matched	The FGFR2 p.M1 mutation disrupts translation start. It is uncertain if this mutation is inactivating.	Included	FALSE	NA	20.7	70	SOC	No	2015, Wk. 34	NA
lung_msk_mind_2020	P-0006071	P-0006071-T01-IM5	53	53	4.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	93.4	17.7	91.7	NA	8/20/15	No durable clinical benefit	20032	NSCLC	1.1	19503	19368	1	FALSE	NA	FALSE	NA	20032	0.4911	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2015/08	NA	3.99	Indeterminate	NA	18	LUAD	21.8	NA	40	NO	pleura	19510	4.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	752	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: The SMAD4 exon9 mutations all occur in cis (same allele).      Note: Copy number profile is suggestive of an intrangenic gain of NCOA3 exons 2-17.	Included	TRUE	Q220* (driver)	17.7	70	SOC	Yes	2015, Wk. 34	NA
lung_msk_mind_2020	P-0006516	P-0006516-T01-IM5	73	74	2.4	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	2	16.2	NA	9/16/15	NA	26775	NSCLC	5.5	26761	26747	1	FALSE	NA	FALSE	NA	26775	0.0054	IMPACT410	50	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2015/09	NA	0	Stable	1142945	2	LUAD	0.9	NA	55.2	YES	pleura	26775	0.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	888	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	2	10	SOC	Yes	2015, Wk. 38	NA
lung_msk_mind_2020	P-0006607	P-0006607-T01-IM5	61	62	4.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	2	16.2	NA	9/29/15	Durable clinical benefit	NA	NSCLC	2.3	22993	22463	1	FALSE	NA	FALSE	NA	23694	0.0039	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Ipilimumab+Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1+CTLA4	2015/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	NA	2	LUAD	NA	NA	0	NO	lung	22750	9.4	1:PROGRESS	Lung	15-251	FALSE	NA	FALSE	NA	Tumor	1	699	Primary	Male	Never smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	2	20	Clinical trial	No	2015, Wk. 40	NA
lung_msk_mind_2020	P-0006663	P-0006663-T01-IM5	64	64	4.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	93.8	18.7	92.4	NA	10/2/15	NA	NA	NSCLC	2.9	24421	23441	0	FALSE	NA	FALSE	NA	24421	0.0603	IMPACT410	90	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2015/10	NA	0	Stable	NA	20	LUAD	NA	NA	30	NO	lymph node	24378	30.8	0:CENSORED	Lung	NA	FALSE	NA	FALSE	Y802C	Tumor	1	830	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	D194Y (driver)	18.7	10	SOC	No	2015, Wk. 40	NA
lung_msk_mind_2020	P-0006713	P-0006713-T01-IM5	52	53	4.6	FALSE	NA	NO	TRUE	C2094Ffs*41 (driver)	SD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	20	NA	CT chest/abdomen/pelvis	97.8	45.3	99.3	NA	10/7/15	Durable clinical benefit	NA	NSCLC	1.5	19284	19044	1	FALSE	A24S	FALSE	NA	20342	0.5048	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	NA	NA	Liver	FALSE	NA	NA	PD1 alone	2015/10	MICROSATELLITE STABLE (MSS). See MSI note below.	2.96	Stable	NA	46	LUAD	NA	NA	25	NO	liver	19302	8.5	1:PROGRESS	Lung	NA	FALSE	H352P	FALSE	NA	Tumor	1	946	Metastasis	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	45.3	50	SOC	No	2015, Wk. 41	NA
lung_msk_mind_2020	P-0006768	P-0006768-T01-IM5	66	67	4.2	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	79.1	7.9	63.8	NA	10/9/15	No durable clinical benefit	25287	NSCLC	3.8	24550	24423	0	TRUE	AMP (driver), EGFR-intragenic	FALSE	NA	25287	0.2796	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2015/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.57	Stable	1142908	8	LUAD	28.4	NA	30	YES	liver	24551	4.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1424	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	S428L	7.9	50	SOC	Yes	2015, Wk. 41	NA
lung_msk_mind_2020	P-0007068	P-0007068-T01-IM5	65	65	4.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest	85	8.9	72.9	NA	10/23/15	NA	23889	NSCLC	6.2	23752	23710	1	FALSE	NA	FALSE	NA	23889	0.3010	IMPACT410	70	Squamous	No	MSKCC	Nivolumab	1	20	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2015/10	NA	0.26	Stable	1142888	9	LUSC	5.9	NA	21.5	YES	lung	23773	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	931	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: A comparison of variant frequencies suggests the PIK3R3 p.A397V and p.R309*mutatios are subclonal.	Included	FALSE	NA	8.9	30	SOC	Yes	2015, Wk. 43	NA
lung_msk_mind_2020	P-0007121	P-0007121-T01-IM5	58	59	4.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest	79.1	7.9	63.8	NA	10/25/15	NA	NA	NSCLC	6.2	21717	21374	0	FALSE	NA	FALSE	NA	22582	0.0011	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2015/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	8	LUAD	NA	NA	30	NO	lung	21998	20.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	851	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Excluded	FALSE	NA	7.9	15	SOC	No	2015, Wk. 43	NA
lung_msk_mind_2020	P-0007493	P-0007493-T02-IM5	76	75	4	FALSE	NA	NO	FALSE	H173R	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	95	NA	CT chest/abdomen/pelvis	93.8	18.7	92.4	NA	4/16/16	NA	NA	NSCLC	1.8	28241	27751	1	FALSE	NA	FALSE	NA	28753	0.4615	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	90	No	Bone	FALSE	NA	NA	PD1 alone	2016/04	NA	0.96	Stable	416500	19	LUAD	NA	NA	116	YES	bone	27922	5.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	902	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	18.7	40	SOC	No	2016, Wk. 15	NA
lung_msk_mind_2020	P-0008422	P-0008422-T03-IM6	69	70	3.9	FALSE	E275*	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	40	NA	CT chest	63.5	5.3	46.4	NA	8/27/17	NA	NA	NSCLC	3.3	26131	25375	0	FALSE	NA	FALSE	NA	26145	0.5332	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	1	30	No	NA	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	2.32	Stable	678801	6	LUSC	NA	NA	30	YES	lung	26043	21.9	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	690	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	5.3	40	SOC	No	2017, Wk. 34	NA
lung_msk_mind_2020	P-0008645	P-0008645-T02-IM6	47	47	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	37.9	2.6	25.7	NA	3/10/17	NA	17261	NSCLC	5.6	17224	17196	1	TRUE	E746_A750del (driver)	FALSE	NA	17261	0.0084	IMPACT468	NA	Squamous	Yes	MSKCC	Nivolumab	3	NA	NA	Pleura	FALSE	NA	NA	PD1 alone	2017/03	NA	0	Do not report	560103	3	LUAD	2.1	NA	0	YES	lung	17247	1.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	748	Metastasis	Male	Never smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Excluded	FALSE	NA	2.6	20	SOC	Yes	2017, Wk. 10	NA
lung_msk_mind_2020	P-0008878	P-0008878-T01-IM5	76	74	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	2	NA	CT chest/abdomen/pelvis	68	5.9	50.9	Formalin	1/21/16	NA	28253	NSCLC	3.4	27908	27848	2	FALSE	NA	FALSE	NA	28253	0.0854	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	NA	NA	Liver	FALSE	NA	NA	PD1 alone	2016/01	NA	0.3	Stable	NA	6	LUAD	13.3	NA	20	NO	lymph node	27930	2.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1059	Metastasis	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	5.9	40	SOC	Yes	2016, Wk. 03	NA
lung_msk_mind_2020	P-0008944	P-0008944-T01-IM5	46	47	3.2	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	100	NA	CT chest/abdomen/pelvis	87.8	10.8	78.6	NA	1/25/16	NA	17270	NSCLC	3.3	16988	16946	1	FALSE	NA	FALSE	NA	17270	0.0425	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2016/01	NA	0.31	Stable	NA	11	LUAD	10.6	NA	24	NO	lung	16994	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	718	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	10.8	40	SOC	Yes	2016, Wk. 04	NA
lung_msk_mind_2020	P-0009017	P-0009017-T01-IM5	77	77	3.6	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	96.7	33.4	98	NA	1/25/16	Durable clinical benefit	NA	NSCLC	3.5	28589	28345	1	FALSE	NA	TRUE	AMP (driver)	28659	0.1702	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2016/01	NA	2.34	Stable	NA	34	LUAD	NA	NA	30	NO	lymph node	28603	8.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1097	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	33.4	40	SOC	No	2016, Wk. 04	NA
lung_msk_mind_2020	P-0009068	P-0009068-T01-IM5	73	74	3.8	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	70	NA	CT chest/abdomen/pelvis	94.1	19.7	93.3	NA	2/5/16	NA	NA	NSCLC	4.1	28264	26995	1	FALSE	NA	FALSE	NA	28264	0.1331	IMPACT410	95	NOS	Yes	MSKCC	Nivolumab	2	90	No	Adrenal Gland	FALSE	NA	NA	PD1 alone	2016/02	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	14.2	Instable	NA	20	NSCLCPD	NA	NA	28.5	NO	adrenal	28221	40.3	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1030	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	19.7	50	SOC	No	2016, Wk. 05	NA
lung_msk_mind_2020	P-0009110	P-0009110-T01-IM5	54	54	3.7	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	92.8	16.7	90.4	NA	1/30/16	NA	NA	NSCLC	3.3	20527	19988	0	FALSE	NA	FALSE	NA	20793	0.0000	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	0	No	NA	FALSE	NA	NA	PD1 alone	2016/01	MICROSATELLITE STABLE (MSS). See MSI note below.	0.31	Stable	399008	17	LUAD	NA	NA	28	YES	lung	20434	14.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1102	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	16.7	10	SOC	No	2016, Wk. 04	NA
lung_msk_mind_2020	P-0009168	P-0009168-T01-IM5	75	75	3.9	FALSE	NA	NO	TRUE	Q520* (driver)	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	96.2	29.5	97.3	NA	2/5/16	Durable clinical benefit	28147	NSCLC	1.1	27743	27647	1	FALSE	NA	FALSE	NA	28147	0.0039	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2016/02	NA	0.08	Stable	NA	29	LUAD	16.4	NA	60	NO	lung	28147	16.4	1:PROGRESS	Lung	NA	FALSE	E61K, Q371K	FALSE	L1945Sfs*17	Tumor	1	1044	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	29.5	20	SOC	Yes	2016, Wk. 05	NA
lung_msk_mind_2020	P-0009202	P-0009202-T01-IM5	66	66	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Lung Squamous Cell Carcinoma	Lung Squamous Cell Carcinoma	60	NA	CT chest/abdomen/pelvis	89	11.8	81.7	NA	2/7/16	NA	NA	NSCLC	3	25305	24252	1	FALSE	NA	FALSE	NA	25305	0.2907	IMPACT410	NA	Squamous	Yes	MSKCC	Nivolumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2016/02	MICROSATELLITE STABLE (MSS). See MSI note below.	1.35	Stable	397796	12	LUSC	NA	NA	29.4	YES	trachea	25242	32.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	649	Primary	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q22-13q34. Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q26-3q28.	Excluded	FALSE	NA	11.8	30	SOC	No	2016, Wk. 05	NA
lung_msk_mind_2020	P-0009256	P-0009256-T01-IM5	75	76	4.2	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.8	74.8	NA	2/17/16	Durable clinical benefit	28469	NSCLC	2.9	27837	27382	1	FALSE	NA	FALSE	NA	28469	0.1587	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2016/02	NA	0.09	Stable	1142994	10	LUAD	35.7	NA	35	YES	lymph node	27606	7.4	1:PROGRESS	Lung	NA	FALSE	P720L	FALSE	NA	Tumor	1	828	Metastasis	Female	Former smoker	Matched	NA	Excluded	TRUE	E165* (driver)	9.8	NA	SOC	Yes	2016, Wk. 07	NA
lung_msk_mind_2020	P-0009473	P-0009473-T01-IM5	79	80	4	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	80	NA	CT chest/abdomen/pelvis	84.8	8.9	72.7	NA	2/19/16	NA	NA	NSCLC	1.5	29554	29082	0	FALSE	NA	FALSE	NA	30389	0.0794	IMPACT410	70	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	80	Yes	NA	FALSE	NA	NA	PD1 alone	2016/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	398027	9	LUAS	NA	NA	9	YES	unknown	30309	40.3	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	709	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	8.9	20	SOC	No	2016, Wk. 07	NA
lung_msk_mind_2020	P-0009476	P-0009476-T01-IM5	58	58	3.3	FALSE	G718A	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest/abdomen/pelvis	78.9	7.9	63.7	NA	2/19/16	NA	21258	NSCLC	6.5	21238	21238	1	FALSE	NA	FALSE	NA	21258	0.1335	IMPACT410	95	NOS	Yes	MSKCC	Pembrolizumab	4	80	No	Spine	FALSE	NA	NA	PD1 alone	2016/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	398112	7	LUAD	0.7	NA	20	YES	skin, muscle, fat	21258	0.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	717	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	7.9	60	SOC	Yes	2016, Wk. 07	NA
lung_msk_mind_2020	P-0009483	P-0009483-T01-IM5	82	82	3.9	FALSE	NA	NO	FALSE	NA	POD	TRUE	G464R (driver)	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.8	74.8	NA	2/21/16	NA	30234	NSCLC	3	30081	29962	0	FALSE	NA	FALSE	NA	30234	0.0000	IMPACT410	80	Adenocarcinoma	No	MSKCC	Nivolumab (+added ipilimumab)	1	0	No	NA	FALSE	NA	NA	PD1+CTLA4	2016/02	NA	0	Stable	398136	10	LUAD	8.9	NA	45	YES	lung	30006	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	802	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	9.8	NA	SOC	Yes	2016, Wk. 07	NA
lung_msk_mind_2020	P-0009952	P-0009952-T01-IM5	63	63	3.7	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest	13.1	1	7.8	Cytolyt	3/13/16	NA	23736	NSCLC	2.8	23399	23343	0	FALSE	NA	FALSE	NA	23736	0.0079	IMPACT410	50	Squamous	Yes	MSKCC	Nivolumab	2	50	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2016/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	405370	1	LUSC	12.9	NA	23	YES	lymph node	23407	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1101	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	1	10	SOC	Yes	2016, Wk. 10	NA
lung_msk_mind_2020	P-0009959	P-0009959-T01-IM5	66	66	3.4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	37.9	3	25.7	NA	3/13/16	No durable clinical benefit	24670	NSCLC	2.7	24560	24279	1	FALSE	NA	FALSE	NA	24670	0.1985	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	NA	NA	FALSE	NA	NA	PD1 alone	2016/03	NA	0.61	Stable	404220	3	LUAD	12.8	NA	36	YES	lung	24455	5.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1367	Primary	Male	Former smoker	Matched	NA	Excluded	TRUE	X245_splice (driver)	3	20	SOC	Yes	2016, Wk. 10	NA
lung_msk_mind_2020	P-0010063	P-0010063-T01-IM5	73	73	4.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	59.8	4.9	43	NA	3/19/16	NA	27597	NSCLC	1.7	27078	27007	0	FALSE	NA	FALSE	NA	27597	0.0926	IMPACT410	80	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/03	NA	0.31	Stable	404041	4	LUAD	19.4	NA	6	YES	lung	27087	2.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1157	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	4.9	40	SOC	Yes	2016, Wk. 11	NA
lung_msk_mind_2020	P-0010215	P-0010215-T01-IM5	73	74	3.5	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	74.4	6.9	57.5	NA	3/27/16	NA	27063	NSCLC	3.4	26969	26969	0	FALSE	NA	TRUE	G778_P780dup (driver)	27063	0.1100	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	0	No	Bone	FALSE	NA	NA	PD1 alone	2016/03	NA	0.29	Stable	574794	7	LUAD	3.1	NA	1.4	YES	bone	26976	0.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	856	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	6.9	20	SOC	Yes	2016, Wk. 12	NA
lung_msk_mind_2020	P-0010300	P-0010300-T01-IM5	55	54	2.8	FALSE	NA	NO	FALSE	NA	POD/clinical	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	49.7	3.9	34.6	NA	3/31/16	NA	20258	NSCLC	4.1	20157	20137	1	FALSE	NA	TRUE	AMP (driver), L755P (driver)	20258	0.1261	IMPACT410	NA	Adenocarcinoma; Adenocarcinoma In Situ	Yes	MSKCC	Atezolizumab	3	NA	NA	NA	FALSE	NA	NA	PD1 alone	2016/03	NA	0.74	Stable	413335	4	LUAD	4	NA	0	YES	lung	20180	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	882	Primary	Male	Former smoker	Matched	Note: A comparison of variant frequency suggests that ERBB2 p.L755P mutation likely occurs on the amplified allele.	Excluded	FALSE	NA	3.9	50	SOC	Yes	2016, Wk. 13	NA
lung_msk_mind_2020	P-0010507	P-0010507-T03-IM6	83	82	4.3	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	4/5/17	NA	NA	NSCLC	1.2	30633	30549	1	FALSE	NA	FALSE	NA	30868	0.0905	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/04	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	589024	2	LUAD	NA	NA	0	YES	lung	30673	4.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	802	Primary	Male	Never smoker	Matched	NA	Included	FALSE	STK11-intragenic	1.8	30	SOC	No	2017, Wk. 14	NA
lung_msk_mind_2020	P-0010514	P-0010514-T01-IM5	63	62	3.4	FALSE	F255L	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	90	NA	CT chest	59.8	4.9	43	NA	4/9/16	NA	NA	NSCLC	0.9	23525	23098	1	FALSE	NA	FALSE	NA	23910	0.5350	IMPACT410	50	Adenocarcinoma	No	MSKCC	Pembrolizumab	4	90	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2016/04	NA	3.85	Indeterminate	413900	5	NSCLC	NA	NA	54	YES	mediastinum	23308	6.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	80	Metastasis	Female	Former smoker	Matched	Note: Low sequencing depth of coverage of 80X, negative results should be interpreted with caution.	Included	FALSE	NA	4.9	50	SOC	No	2016, Wk. 14	NA
lung_msk_mind_2020	P-0010648	P-0010648-T01-IM5	73	73	4.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	2	16.2	NA	4/19/16	NA	27330	NSCLC	1.2	26853	26792	1	FALSE	NA	FALSE	NA	27330	0.1806	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	NA	NA	Bone	FALSE	NA	NA	PD1 alone	2016/04	NA	0.73	Stable	413386	2	LUAD	17.7	NA	50	YES	bone	26853	2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	553	Metastasis	Male	Former smoker	Matched	NA	Excluded	TRUE	H174R (driver)	2	40	SOC	Yes	2016, Wk. 16	NA
lung_msk_mind_2020	P-0010840	P-0010840-T02-IM5	55	56	3.7	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	87.8	10.8	78.6	NA	5/20/16	NA	20225	NSCLC	4.1	20173	20154	1	FALSE	NA	FALSE	NA	20225	0.0628	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2016/05	NA	1.32	Stable	434510	11	LUAD	2.3	NA	15	YES	soft tissue (neck)	20179	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	313	Metastasis	Female	Former smoker	Matched	>2% minor contamination	Excluded	TRUE	E120* (driver)	10.8	20	SOC	Yes	2016, Wk. 20	NA
lung_msk_mind_2020	P-0010927	P-0010927-T03-IM6	67	68	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	9/20/17	NA	NA	NSCLC	2.2	25228	24493	0	FALSE	NA	TRUE	L755P (driver)	25228	0.0624	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	4	50	No	Lumbar spine	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	725884	5	LUAD	NA	NA	8	YES	soft tissue (L3)	25224	24	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	762	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	4.4	30	SOC	No	2017, Wk. 38	NA
lung_msk_mind_2020	P-0010980	P-0010980-T02-IM6	75	75	4.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	2/17/18	NA	27941	NSCLC	4.5	27591	27570	1	FALSE	NA	FALSE	NA	27941	0.2698	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	1	No	NA	FALSE	NA	NA	PD1 alone	2018/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0.78	Stable	945580	9	LUAD	12.2	NA	11	YES	lung	27609	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	796	Primary	Female	Former smoker	Matched	NA	Included	TRUE	W308C (driver)	8.8	40	SOC	Yes	2018, Wk. 07	NA
lung_msk_mind_2020	P-0011260	P-0011260-T01-IM5	47	48	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	50	NA	CT chest/abdomen/pelvis	89.2	11.8	81.4	NA	5/18/16	NA	17196	NSCLC	2.5	17151	17151	1	FALSE	NA	FALSE	NA	17196	0.1724	IMPACT410	95	Adenocarcinoma	No	MSKCC	Durvalumab+Tremelimumab	2	50	No	Pleural Fluid	FALSE	NA	NA	PD1+CTLA4	2016/05	MICROSATELLITE STABLE (MSS). See MSI note below.	0.54	Stable	1142966	12	LUAD	1.5	NA	9	YES	lung	17169	0.6	1:PROGRESS	Lung	13-197	FALSE	NA	FALSE	NA	Tumor	1	1035	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	11.8	80	Clinical trial	Yes	2016, Wk. 20	NA
lung_msk_mind_2020	P-0011537	P-0011537-T02-IM6	70	70	3.9	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	30	NA	CT chest	44.1	3.5	30.4	NA	3/27/17	Durable clinical benefit	NA	NSCLC	2	25905	25688	1	FALSE	NA	FALSE	NA	26374	0.7981	IMPACT468	95	Squamous	No	MSKCC	Pembrolizumab	1	30	No	NA	FALSE	NA	NA	PD1 alone	2017/03	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	2.24	Stable	583617	4	LUSC	NA	NA	6.25	YES	chest wall	26163	15.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	909	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Included	FALSE	NA	3.5	50	SOC	No	2017, Wk. 13	NA
lung_msk_mind_2020	P-0012056	P-0012056-T02-IM6	63	65	3.8	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	8/18/17	NA	23466	NSCLC	2.9	23377	23356	1	FALSE	G1185S	TRUE	AMP (driver)	23466	0.3752	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	NA	NA	Liver	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	708108	12	LUAD	3.6	NA	70	YES	liver	23397	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	721	Metastasis	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	10.5	20	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0012090	P-0012090-T01-IM5	79	79	3.8	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	68	5.9	50.9	NA	6/10/16	NA	29064	NSCLC	4.2	29041	29041	1	FALSE	NA	TRUE	Y772_A775dup (driver)	29064	0.0090	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	3	0	No	NA	FALSE	NA	NA	PD1 alone	2016/06	NA	0.15	Stable	405452	6	LUAD	0.8	NA	15	YES	lung	29064	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	988	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	5.9	40	SOC	Yes	2016, Wk. 23	NA
lung_msk_mind_2020	P-0012149	P-0012149-T01-IM5	69	71	4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest/abdomen/pelvis	13.1	1	7.8	NA	6/10/16	No durable clinical benefit	NA	NSCLC	0.6	25564	25410	1	FALSE	NA	FALSE	NA	26612	0.0014	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Ipilimumab+Nivolumab	1	NA	NA	NA	TRUE	X1010_splice (driver)	NA	PD1+CTLA4	2016/06	NA	0	Stable	434420	1	LUAD	NA	NA	7.5	YES	lung	25572	5.3	1:PROGRESS	Lung	16-183	FALSE	NA	FALSE	NA	Tumor	1	970	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Excluded	FALSE	NA	1	10	Clinical trial	No	2016, Wk. 23	NA
lung_msk_mind_2020	P-0012341	P-0012341-T01-IM5	72	73	3.3	FALSE	NA	NO	TRUE	Q354* (driver)	POD	TRUE	V600E (driver)	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	68	5.9	50.9	Cytolyt	6/15/16	NA	26445	NSCLC	6.5	26373	26360	1	FALSE	NA	FALSE	NA	26445	0.0362	IMPACT410	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	NA	Omentum	FALSE	NA	NA	PD1 alone	2016/06	NA	0.07	Stable	437862	6	LUAD	2.8	NA	0	YES	ascites	26379	0.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	885	Metastasis	Female	Never smoker	Matched	NA	Excluded	FALSE	NA	5.9	30	SOC	Yes	2016, Wk. 24	NA
lung_msk_mind_2020	P-0012476	P-0012476-T02-IM6	84	84	4	FALSE	NA	NO	FALSE	A1029S	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	3/2/17	No durable clinical benefit	31076	NSCLC	2	30871	30871	1	FALSE	NA	FALSE	NA	31076	0.0066	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/03	NA	0	Do not report	NA	12	LUAD	6.7	NA	50	NO	bone	30966	3.1	1:PROGRESS	Lung	NA	FALSE	C528S	FALSE	NA	Tumor	1	726	Primary	Female	Former smoker	Matched	NA	Included	TRUE	P281Rfs*6 (driver)	10.5	20	SOC	Yes	2017, Wk. 09	NA
lung_msk_mind_2020	P-0012679	P-0012679-T01-IM5	57	58	3.7	FALSE	EML4-ALK fusion	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest/abdomen/pelvis	49.7	3.9	34.6	NA	6/29/16	NA	21027	NSCLC	3.6	20993	20993	1	FALSE	NA	FALSE	NA	21027	0.2179	IMPACT410	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	7	60	No	Liver	FALSE	NA	NA	PD1 alone	2016/06	NA	0.16	Stable	448837	4	LUAD	1.1	NA	0	YES	liver	21027	1.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1071	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	3.9	40	SOC	Yes	2016, Wk. 26	NA
lung_msk_mind_2020	P-0012894	P-0012894-T01-IM5	58	58	4.1	FALSE	NA	NO	FALSE	NA	POD	TRUE	N581I (driver)	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	2	16.2	Cytolyt	7/12/16	NA	21343	NSCLC	4	21224	21184	1	FALSE	NA	FALSE	NA	21343	0.0116	IMPACT410	90	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/07	NA	0	Stable	NA	2	LUAD	5.2	NA	12.75	NO	lymph node	21234	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	842	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	2	40	SOC	Yes	2016, Wk. 28	NA
lung_msk_mind_2020	P-0013406	P-0013406-T01-IM5	69	70	2.5	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest/abdomen/pelvis	NA	NA	NA	NA	8/4/16	NA	25370	NSCLC	6.5	25351	25351	1	FALSE	NA	FALSE	NA	25370	0.0029	IMPACT410	80	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	60	Yes	Pleura	FALSE	NA	NA	PD1 alone	2016/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	458585	NA	LUAD	0.6	NA	0	YES	pleura	25370	0.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1023	Metastasis	Male	Never smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution. Repeat testing is recommended on a separate tumor block.	Included	FALSE	NA	0	10	SOC	Yes	2016, Wk. 31	NA
lung_msk_mind_2020	P-0013653	P-0013653-T01-IM5	69	71	4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	84.8	8.9	72.7	NA	8/17/16	No durable clinical benefit	NA	NSCLC	2.4	25759	25500	1	FALSE	NA	FALSE	NA	26655	0.0024	IMPACT410	70	Adenocarcinoma	Yes	MSKCC	Durvalumab+Tremelimumab	2	20	Yes	NA	FALSE	NA	NA	PD1+CTLA4	2016/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	458240	9	LUAD	NA	NA	48	YES	lung	25663	5.4	1:PROGRESS	Lung	13-197	FALSE	NA	FALSE	NA	Tumor	1	1071	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	8.9	20	Clinical trial	No	2016, Wk. 33	NA
lung_msk_mind_2020	P-0013656	P-0013656-T01-IM5	55	56	4.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	50	NA	CT chest/abdomen/pelvis	49.7	3.9	34.6	NA	8/17/16	NA	20508	NSCLC	2.5	20438	20364	1	FALSE	NA	FALSE	NA	20508	0.0495	IMPACT410	70	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	60	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2016/08	NA	0	Stable	448839	4	LUAD	4.7	NA	15	YES	lymph node	20447	2.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1049	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	3.9	20	SOC	Yes	2016, Wk. 33	NA
lung_msk_mind_2020	P-0013719	P-0013719-T01-IM5	68	67	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest/abdomen/pelvis	68	5.9	50.9	NA	8/18/16	NA	25371	NSCLC	1.2	24873	24827	1	TRUE	L858R (driver)	FALSE	NA	25371	0.1299	IMPACT410	60	Adenocarcinoma	No	MSKCC	Atezolizumab	4	60	Yes	Bone	FALSE	NA	NA	PD1 alone	2016/08	NA	0.14	Stable	460099	6	LUAD	17.9	NA	0	YES	bone	24893	2.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	964	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	5.9	30	SOC	Yes	2016, Wk. 33	NA
lung_msk_mind_2020	P-0013831	P-0013831-T01-IM5	58	58	4	FALSE	S62L	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor	30	NA	CT chest/abdomen/pelvis	98	47.2	100	NA	8/26/16	NA	21288	NSCLC	10.1	21244	21229	1	FALSE	NA	FALSE	NA	21288	0.5173	IMPACT410	NA	Large cell neuroendocrine	Yes	MSKCC	Nivolumab	2	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2016/08	NA	2.46	Do not report	467652	48	LNET	1.9	NA	37	YES	lymph node	21288	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	989	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Excluded	FALSE	NA	47.2	20	SOC	Yes	2016, Wk. 34	NA
lung_msk_mind_2020	P-0014061	P-0014061-T02-IM6	74	74	4	FALSE	R121Q	NO	TRUE	E1774* (driver)	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest	95.5	25.5	96.4	NA	4/25/18	Durable clinical benefit	NA	NSCLC	1.9	27558	27192	1	FALSE	NA	FALSE	NA	27577	0.2561	IMPACT468	60	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	90	Yes	Brain	FALSE	NA	NA	PD1 alone	2018/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0.16	Stable	1016803	29	LUAD	NA	NA	46	YES	lung	27484	9.6	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	644	Metastasis	Female	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p.	Included	FALSE	R40L	25.5	60	SOC	No	2018, Wk. 17	NA
lung_msk_mind_2020	P-0014065	P-0014065-T01-IM5	53	53	3.9	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest	25.2	2	16.2	NA	9/3/16	NA	NA	NSCLC	1	20031	19396	1	FALSE	NA	FALSE	NA	20031	0.1190	IMPACT410	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	95	No	Lung	FALSE	NA	NA	PD1 alone	2016/09	NA	0.23	Do not report	472754	2	LUAD	NA	NA	10	YES	lung	20006	20	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	674	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	2	60	SOC	No	2016, Wk. 35	NA
lung_msk_mind_2020	P-0014207	P-0014207-T01-IM6	78	80	3.2	FALSE	NA	NO	TRUE	Q521* (driver)	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	40	NA	CT chest/abdomen/pelvis	76.6	7	60.3	NA	9/15/16	NA	28907	NSCLC	3.9	28860	28797	1	FALSE	NA	FALSE	NA	28907	0.0123	IMPACT468	95	NOS	No	MSKCC	Pembrolizumab	1	80	No	Lymph Node	FALSE	NA	NA	PD1 alone	2016/09	NA	0	Do not report	476967	8	LUAD	3.6	NA	35	YES	bone	28854	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	619	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	Included	FALSE	V110D	7	10	SOC	Yes	2016, Wk. 37	NA
lung_msk_mind_2020	P-0014285	P-0014285-T02-IM6	62	62	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest/abdomen/pelvis	44.1	3.5	30.4	NA	10/4/16	NA	NA	NSCLC	2.4	23095	22761	0	FALSE	NA	FALSE	NA	23490	0.0623	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	95	No	NA	FALSE	NA	NA	PD1 alone	2016/10	NA	0.06	Do not report	NA	4	LUAD	NA	NA	15	NO	lymph node	23125	12	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	834	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	3.5	10	SOC	No	2016, Wk. 40	NA
lung_msk_mind_2020	P-0014293	P-0014293-T01-IM6	88	87	3.7	FALSE	E273*	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	70	NA	CT chest/abdomen/pelvis	89.7	12.3	82.3	NA	9/17/16	NA	NA	NSCLC	2.4	32657	32293	1	FALSE	NA	FALSE	NA	32678	0.3482	IMPACT468	95	NOS	Yes	MSKCC	Pembrolizumab	2	90	No	Brain	FALSE	NA	NA	PD1 alone	2016/09	NA	0.91	Do not report	470296	14	LUAD	NA	NA	30	YES	brain	32613	10.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	586	Metastasis	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 5p including TERT and 7p including EGFR.	Included	FALSE	NA	12.3	50	SOC	No	2016, Wk. 37	NA
lung_msk_mind_2020	P-0014319	P-0014319-T01-IM6	73	74	3.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	Cytolyt	9/22/16	NA	27069	NSCLC	5.7	26959	26937	1	FALSE	NA	FALSE	NA	27069	0.3658	IMPACT468	95	Adenocarcinoma	No	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/09	NA	0.99	Do not report	479993	3	LUAD	4.3	NA	12.5	YES	lung	26959	0.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	684	Primary	Female	Former smoker	Matched	NA	Included	TRUE	HOMDEL (driver)	2.6	40	SOC	Yes	2016, Wk. 38	NA
lung_msk_mind_2020	P-0014328	P-0014328-T01-IM6	61	62	3.1	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	0	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	9/22/16	NA	22502	NSCLC	2.3	22478	22478	0	FALSE	NA	FALSE	NA	22502	0.5612	IMPACT468	NA	Large cell neuroendocrine	Yes	MSKCC	Ipilimumab+Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1+CTLA4	2016/09	NA	2.89	Do not report	479988	6	LUNE	0.8	NA	20	YES	lymph node	22502	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1288	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	5.3	80	SOC	Yes	2016, Wk. 38	NA
lung_msk_mind_2020	P-0014451	P-0014451-T01-IM6	64	66	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	9/27/16	NA	23913	NSCLC	1.7	23714	23684	1	TRUE	L858R (driver)	FALSE	NA	23913	0.3830	IMPACT468	70	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/09	NA	0.69	Do not report	484466	11	LUAD	7.5	NA	15	YES	lung	23702	0.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	375	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	9.7	20	SOC	Yes	2016, Wk. 39	NA
lung_msk_mind_2020	P-0014458	P-0014458-T01-IM6	83	84	3.7	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	60	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	9/27/16	Durable clinical benefit	30937	NSCLC	1	30359	30331	1	FALSE	NA	FALSE	NA	30937	0.0601	IMPACT468	NA	Squamous	No	MSKCC	Ipilimumab+Nivolumab	1	NA	NA	NA	FALSE	NA	NA	PD1+CTLA4	2016/09	NA	0	Do not report	468098	5	NSCLCPD	19.9	NA	4	YES	lung	30937	19.9	1:PROGRESS	Lung	16-183	FALSE	NA	FALSE	NA	Tumor	1	962	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Excluded	FALSE	NA	4.4	10	Clinical trial	Yes	2016, Wk. 39	NA
lung_msk_mind_2020	P-0014529	P-0014529-T01-IM6	65	66	4.4	FALSE	NA	NO	FALSE	NA	PR	FALSE	S616Y	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	20	NA	CT chest	94.6	21.1	94.5	NA	9/27/16	NA	NA	NSCLC	3.1	24992	23918	1	FALSE	NA	FALSE	NA	24992	0.3929	IMPACT468	NA	Squamous	Yes	MSKCC	Nivolumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2016/09	NA	2.08	Do not report	483348	22	LUSC	NA	NA	30	YES	lung	24954	34	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1150	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	21.1	30	SOC	No	2016, Wk. 39	NA
lung_msk_mind_2020	P-0014736	P-0014736-T01-IM6	63	64	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	63.5	5.3	46.4	NA	10/7/16	NA	23327	NSCLC	3.8	23295	23295	1	FALSE	NA	FALSE	NA	23327	0.0018	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Chest wall soft tissue	FALSE	NA	NA	PD1 alone	2016/10	NA	0	Do not report	NA	6	LUAD	1.1	NA	7.5	NO	soft tissue (chest wall)	23309	0.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	990	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	5.3	10	SOC	Yes	2016, Wk. 40	NA
lung_msk_mind_2020	P-0014764	P-0014764-T01-IM6	67	68	3.6	FALSE	NA	NO	FALSE	NA	POD/clinical	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	10/8/16	NA	24862	NSCLC	6.6	24817	24817	1	FALSE	NA	FALSE	NA	24862	0.0294	IMPACT468	NA	NOS	Yes	MSKCC	Atezolizumab	2	0	No	Rib	FALSE	NA	NA	PD1 alone	2016/10	NA	0.07	Do not report	490604	5	NSCLCPD	1.5	NA	0	YES	bone	24846	1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	738	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	4.4	10	SOC	Yes	2016, Wk. 40	NA
lung_msk_mind_2020	P-0014885	P-0014885-T01-IM6	54	55	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	10/17/16	NA	NA	NSCLC	2.1	19910	19804	1	TRUE	G719S (driver), E709A (driver)	FALSE	NA	20226	0.0000	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	95	No	Lymph node	FALSE	NA	NA	PD1 alone	2016/10	NA	0.06	Do not report	492913	2	LUAD	NA	NA	6	YES	lymph node	19883	2.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	695	Metastasis	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	1.8	20	SOC	No	2016, Wk. 42	NA
lung_msk_mind_2020	P-0015075	P-0015075-T01-IM6	59	60	3.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	10/25/16	NA	22030	NSCLC	6.2	21729	21687	1	TRUE	L858R (driver)	FALSE	NA	22030	0.0026	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	4	0	No	NA	FALSE	NA	NA	PD1 alone	2016/10	NA	0.07	Do not report	484513	6	LUAD	11.3	NA	10	YES	lung	21698	0.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	869	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	5.3	20	SOC	Yes	2016, Wk. 43	NA
lung_msk_mind_2020	P-0015213	P-0015213-T01-IM6	69	69	4.3	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest	76.6	7	60.3	NA	11/1/16	NA	25338	NSCLC	5.1	25311	25268	1	FALSE	NA	FALSE	NA	25338	0	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2016/11	NA	0	Do not report	501773	8	LUAD	2.3	NA	70	YES	lymph node	25338	2.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	903	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Excluded	TRUE	W239L (driver)	7	20	SOC	Yes	2016, Wk. 44	NA
lung_msk_mind_2020	P-0015296	P-0015296-T01-IM6	67	69	3.8	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	100	NA	CT chest/abdomen/pelvis	94.3	20.2	93.7	NA	11/3/16	NA	NA	NSCLC	1.9	25034	24770	0	FALSE	NA	FALSE	NA	25503	0.2041	IMPACT468	95	NOS	Yes	MSKCC	Pembrolizumab	1	95	No	Adrenal Gland	TRUE	AMP (driver)	NA	PD1 alone	2016/11	NA	1.69	Do not report	501592	23	NSCLCPD	NA	NA	35	YES	adrenal	25223	14.9	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	893	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	20.2	70	SOC	No	2016, Wk. 44	NA
lung_msk_mind_2020	P-0015348	P-0015348-T01-IM6	62	63	3.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	11/4/16	NA	23293	NSCLC	4.1	22821	22770	2	FALSE	NA	FALSE	NA	23293	0.2869	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	Bone	FALSE	NA	NA	PD1 alone	2016/11	NA	0.52	Do not report	503153	12	LUAD	17.2	NA	35	YES	chest wall	22834	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	788	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	10.5	20	SOC	Yes	2016, Wk. 44	NA
lung_msk_mind_2020	P-0015529	P-0015529-T01-IM6	76	76	3.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	73.7	6.1	56.8	NA	12/1/16	NA	27875	NSCLC	2.1	27872	27816	1	FALSE	NA	FALSE	NA	27875	0.0048	IMPACT468	95	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	Soft Tissue	FALSE	NA	NA	PD1 alone	2016/12	NA	0	Do not report	506109	7	LUAD	1.9	NA	98	YES	soft tissue (glenoid)	27872	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	723	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	X199_splice (driver)	6.1	20	SOC	Yes	2016, Wk. 48	NA
lung_msk_mind_2020	P-0015693	P-0015693-T01-IM6	79	80	4.1	FALSE	NA	YES	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest	37.9	2.6	25.7	NA	12/1/16	NA	NA	NSCLC	2	29151	29132	1	FALSE	NA	FALSE	NA	29179	0.0000	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Ipilimumab+Nivolumab	1	5	No	NA	FALSE	NA	NA	PD1+CTLA4	2016/12	NA	0	Do not report	513235	3	LUAD	NA	NA	0	YES	pleura	29165	1.1	1:PROGRESS	Lung	16-183	FALSE	NA	FALSE	NA	Tumor	1	773	Primary	Male	Never smoker	Matched	NA	Included	FALSE	NA	2.6	20	Clinical trial	No	2016, Wk. 48	NA
lung_msk_mind_2020	P-0015749	P-0015749-T01-IM6	68	69	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	12/1/16	NA	25439	NSCLC	0.7	25117	25054	1	FALSE	NA	FALSE	NA	25439	0.3106	IMPACT468	NA	Squamous	Yes	MSKCC	Atezolizumab	2	0	No	Pleura	FALSE	NA	NA	PD1 alone	2016/12	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	NA	10	LUSC	12.6	NA	46	NO	pleura	25141	2.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	886	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	8.8	30	SOC	Yes	2016, Wk. 48	NA
lung_msk_mind_2020	P-0015937	P-0015937-T01-IM6	73	74	3.2	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	75	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	12/6/16	NA	27796	NSCLC	4.8	26845	26782	1	TRUE	AMP (driver), L858R (driver)	FALSE	NA	27796	0.5535	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Pembrolizumab	5	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2016/12	NA	2.58	Do not report	516473	12	LUAD	33.3	NA	0	YES	lung	26862	2.6	1:PROGRESS	Lung	NA	FALSE	A479P	FALSE	NA	Tumor	1	311	Metastasis	Female	Never smoker	Matched	NA	Excluded	FALSE	NA	10.5	30	SOC	Yes	2016, Wk. 49	NA
lung_msk_mind_2020	P-0015950	P-0015950-T01-IM6	60	61	4.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	12/6/16	NA	NA	NSCLC	1.6	22218	22190	1	FALSE	NA	TRUE	G778_P780dup (driver)	23243	0.4418	IMPACT468	95	Squamous	Yes	MSKCC	Ipilimumab+Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1+CTLA4	2016/12	NA	1.79	Do not report	517743	5	LUAD	NA	NA	6	YES	lung	22226	1.2	1:PROGRESS	Lung	16-183	FALSE	NA	FALSE	NA	Tumor	1	942	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	4.4	40	Clinical trial	No	2016, Wk. 49	NA
lung_msk_mind_2020	P-0015987	P-0015987-T01-IM6	70	71	4.1	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	12/6/16	NA	25975	NSCLC	3.8	25946	25662	1	FALSE	NA	FALSE	NA	25975	0.3703	IMPACT468	60	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	No	Liver	FALSE	NA	NA	PD1 alone	2016/12	NA	1.67	Do not report	504637	9	LUAD	10.3	NA	20	YES	liver	25760	3.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	929	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	G163V (driver)	7.9	60	SOC	Yes	2016, Wk. 49	NA
lung_msk_mind_2020	P-0016016	P-0016016-T01-IM6	82	83	4.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	30	NA	CT chest/abdomen/pelvis	89.2	11.4	81.4	NA	12/6/16	NA	30388	NSCLC	2.6	30286	30200	1	FALSE	NA	FALSE	NA	30388	0.0514	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	50	No	NA	FALSE	NA	NA	PD1 alone	2016/12	NA	0.15	Do not report	523096	13	LUAD	6.2	NA	6	YES	lung	30261	2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	744	Primary	Female	Former smoker	Matched	NA	Included	TRUE	Q37* (driver)	11.4	20	SOC	Yes	2016, Wk. 49	NA
lung_msk_mind_2020	P-0016174	P-0016174-T01-IM6	72	73	3.8	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	91.3	14	86.9	NA	12/15/16	NA	27471	NSCLC	2.8	26842	26632	0	FALSE	NA	TRUE	Y772_A775dup (driver)	27471	0.1631	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/12	NA	0.06	Do not report	506050	16	LUAD	27.6	NA	0	YES	lung	26728	3.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	811	Primary	Female	Never smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	14	20	SOC	Yes	2016, Wk. 50	NA
lung_msk_mind_2020	P-0016175	P-0016175-T01-IM6	76	77	2.9	FALSE	NA	YES	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	25	NA	CT chest/abdomen/pelvis	92.3	14.9	89.1	NA	12/16/16	NA	27919	NSCLC	8.4	27877	27877	1	FALSE	NA	FALSE	NA	27919	0.3645	IMPACT468	95	Adenocarcinoma	No	MSKCC	Nivolumab	2	75	No	Bone	FALSE	NA	NA	PD1 alone	2016/12	NA	0.36	Do not report	479340	17	LUAD	1.4	NA	45	YES	lung	27919	1.4	1:PROGRESS	Lung	NA	FALSE	R820C	FALSE	ROS1-EYS fusion	Tumor	1	806	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	G251C (driver)	14.9	30	SOC	Yes	2016, Wk. 50	NA
lung_msk_mind_2020	P-0016185	P-0016185-T01-IM6	72	73	3.1	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	12/15/16	NA	26787	NSCLC	2	26612	26510	1	FALSE	NA	FALSE	NA	26787	0.4333	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2016/12	NA	1.13	Do not report	479305	7	LUAD	9.1	NA	45	YES	lung	26616	3.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	594	Primary	Male	Former smoker	Matched	NA	Included	FALSE	E57_G58del	6.1	10	SOC	Yes	2016, Wk. 50	NA
lung_msk_mind_2020	P-0016224	P-0016224-T01-IM6	69	70	4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	93.7	18.4	92.4	NA	1/13/17	Durable clinical benefit	25676	NSCLC	3	25561	25438	1	FALSE	NA	FALSE	NA	25676	0.1560	IMPACT468	50	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Bone	FALSE	NA	NA	PD1 alone	2017/01	NA	0.42	Do not report	525623	21	LUAD	7.8	NA	40	YES	bone	25676	7.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	792	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	18.4	10	SOC	Yes	2017, Wk. 02	NA
lung_msk_mind_2020	P-0016542	P-0016542-T01-IM6	79	80	3	FALSE	NA	YES	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	0	NA	CT chest	94.1	19.3	93.3	NA	1/13/17	NA	29098	NSCLC	2.3	29073	29054	2	FALSE	NA	FALSE	NA	29098	0.2238	IMPACT468	NA	Squamous	Yes	MSKCC	Nivolumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/01	NA	0.14	Do not report	530370	22	LUAS	1.4	NA	100	YES	bone	29098	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	878	Primary	Male	Former smoker	Matched	Testing by the Archer FusionPlexTM Custom Solid Panel assay will also be performed if sufficient material remains and the results will be reported in a separate accession number.	Excluded	FALSE	NA	19.3	40	SOC	Yes	2017, Wk. 02	NA
lung_msk_mind_2020	P-0016646	P-0016646-T01-IM6	76	77	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	1/13/17	NA	28177	NSCLC	2.3	28090	28046	1	FALSE	NA	FALSE	NA	28177	0.1839	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	NA	NA	FALSE	NA	NA	PD1 alone	2017/01	NA	0.38	Do not report	453538	11	LUAD	4.3	NA	12	YES	lung	28102	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1126	Primary	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 7q including EGFR.	Excluded	TRUE	C134Lfs*27 (driver)	9.7	20	SOC	Yes	2017, Wk. 02	NA
lung_msk_mind_2020	P-0016692	P-0016692-T01-IM6	71	72	2.6	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	89.7	12.3	82.3	Cytolyt	1/5/17	NA	26430	NSCLC	3.4	26374	26213	1	FALSE	NA	FALSE	NA	26430	0.5184	IMPACT468	90	NOS	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/01	NA	2.45	Do not report	533509	14	LUAD	7.1	NA	30	YES	lung	26248	1.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	W21C	Tumor	1	830	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Relatively low tumor content (approximately 20%). Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinicall	Included	FALSE	NA	12.3	20	SOC	Yes	2017, Wk. 01	NA
lung_msk_mind_2020	P-0017048	P-0017048-T01-IM6	64	64	2.4	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	1/26/17	NA	23408	NSCLC	3.5	23396	23396	2	FALSE	NA	TRUE	AMP (driver), G778_P780dup (driver)	23408	0.1253	IMPACT468	50	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Spine	FALSE	NA	NA	PD1 alone	2017/01	NA	0	Do not report	544253	7	LUAD	0.4	NA	15	YES	bone, soft tissue	23408	0.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	834	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	6.1	20	SOC	Yes	2017, Wk. 04	NA
lung_msk_mind_2020	P-0017106	P-0017106-T01-IM6	67	68	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	1/25/17	NA	NA	NSCLC	4	24726	24681	1	FALSE	NA	FALSE	NA	24771	0.3991	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/01	NA	1.52	Do not report	544308	10	LUAD	NA	NA	60	YES	lung	24747	2.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1005	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	8.8	60	SOC	No	2017, Wk. 04	NA
lung_msk_mind_2020	P-0017184	P-0017184-T01-IM6	69	69	3.8	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	2/2/17	NA	25293	NSCLC	4.7	25278	25278	2	TRUE	L747_T751del (driver)	FALSE	NA	25293	0.0020	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	0	No	Pleura	FALSE	NA	NA	PD1 alone	2017/02	NA	0	Do not report	544194	3	LUAD	0.5	NA	15	YES	pleura	25293	0.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	950	Metastasis	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	2.6	10	SOC	Yes	2017, Wk. 05	NA
lung_msk_mind_2020	P-0017253	P-0017253-T01-IM6	66	67	3.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	X380_splice	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	91.4	14	86.9	NA	1/31/17	NA	NA	NSCLC	4.4	24440	24398	1	FALSE	NA	FALSE	NA	24468	0.0393	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Rib	FALSE	NA	NA	PD1 alone	2017/01	NA	0	Do not report	538583	16	LUAD	NA	NA	70.5	YES	bone	24463	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	L806F	Tumor	1	751	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	14	20	SOC	No	2017, Wk. 05	NA
lung_msk_mind_2020	P-0017437	P-0017437-T01-IM6	67	67	3.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	2/9/17	NA	24921	NSCLC	0.9	24678	24615	1	FALSE	NA	TRUE	Y772_A775dup (driver)	24921	0.2328	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	3	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0.48	Do not report	907663	3	LUAD	10.1	NA	2.5	YES	lung	24688	2.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	784	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	2.6	40	SOC	Yes	2017, Wk. 06	NA
lung_msk_mind_2020	P-0017484	P-0017484-T01-IM6	80	80	3.5	FALSE	NA	NO	FALSE	NA	POD/clinical	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	50	NA	CT chest	89.2	11.4	81.4	NA	2/9/17	NA	NA	NSCLC	3.1	29351	29300	1	FALSE	NA	FALSE	NA	29367	0.0927	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	50	No	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0.5	Do not report	560148	13	NSCLC	NA	NA	60	YES	lung	29358	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	904	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	11.4	40	SOC	No	2017, Wk. 06	NA
lung_msk_mind_2020	P-0017613	P-0017613-T01-IM5	68	68	4.3	FALSE	NA	YES	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest/abdomen/pelvis	25.2	2	16.2	NA	2/16/17	Durable clinical benefit	25478	NSCLC	2.6	25445	25053	2	FALSE	NA	FALSE	NA	25478	0.0000	IMPACT410	70	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	5	Yes	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0.15	Do not report	544119	2	LUAD	14	NA	3.75	YES	lung	25266	7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1047	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	2	10	SOC	Yes	2017, Wk. 07	NA
lung_msk_mind_2020	P-0017637	P-0017637-T01-IM5	73	73	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	2/17/17	NA	27024	NSCLC	2.8	26939	26907	1	FALSE	NA	FALSE	NA	27024	0.0002	IMPACT410	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	5	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0	Do not report	560946	8	LUAD	3.8	NA	25	YES	lung	26960	1.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	860	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	Excluded	TRUE	L282Sfs*5 (driver)	7.9	10	SOC	Yes	2017, Wk. 07	NA
lung_msk_mind_2020	P-0017722	P-0017722-T01-IM6	71	72	4.1	FALSE	NA	NO	FALSE	NA	POD	TRUE	G469A (driver)	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	63.5	5.3	46.4	Cytolyt	2/22/17	NA	26161	NSCLC	1.4	26093	25980	1	FALSE	NA	FALSE	NA	26161	0.0050	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0	Do not report	NA	6	LUAD	5.9	NA	30	NO	lymph node	26019	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	573	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	TRUE	X200_splice (driver)	5.3	10	SOC	Yes	2017, Wk. 08	NA
lung_msk_mind_2020	P-0017735	P-0017735-T01-IM6	66	67	2.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	2/22/17	NA	25076	NSCLC	4.3	24589	24358	1	FALSE	NA	TRUE	AMP (driver)	25076	0.2589	IMPACT468	60	Squamous	Yes	MSKCC	Nivolumab	2	10	Yes	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0.41	Do not report	557474	12	LUSC	23.6	NA	33.75	YES	lung	24476	3.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	994	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	10.5	30	SOC	Yes	2017, Wk. 08	NA
lung_msk_mind_2020	P-0017749	P-0017749-T01-IM6	80	81	3.9	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	79.1	7.9	63.8	NA	2/22/17	No durable clinical benefit	30061	NSCLC	2.2	29596	29437	1	FALSE	NA	FALSE	NA	30061	0.0000	IMPACT468	95	Adenocarcinoma	No	MSKCC	Nivolumab	2	5	No	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0	Do not report	558239	9	LUAD	20.5	NA	37.5	YES	lung	29599	5.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	684	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	TRUE	H174P (driver)	7.9	30	SOC	Yes	2017, Wk. 08	NA
lung_msk_mind_2020	P-0017781	P-0017781-T01-IM6	80	81	3.8	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	SSL	2/25/17	NA	29472	NSCLC	1.1	29440	29426	1	FALSE	NA	FALSE	NA	29472	0.6335	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	3.31	Do not report	556756	5	LUAD	1.5	NA	15	YES	lung	29472	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	509	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	4.4	60	SOC	Yes	2017, Wk. 08	NA
lung_msk_mind_2020	P-0017910	P-0017910-T01-IM6	52	52	4.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	89.2	11.4	81.4	Cytolyt	2/24/17	Durable clinical benefit	NA	NSCLC	2.7	19601	19188	1	FALSE	NA	FALSE	NA	19934	0.1401	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/02	NA	0.15	Do not report	558717	13	LUAD	NA	NA	30	YES	lymph node	19902	23.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	582	Primary	Female	Former smoker	Matched	NA	Included	TRUE	E130* (driver)	11.4	30	SOC	No	2017, Wk. 08	NA
lung_msk_mind_2020	P-0018043	P-0018043-T01-IM6	56	56	4	FALSE	NA	YES	FALSE	NA	POD/bone	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen	76.6	7	60.3	NA	3/2/17	NA	20792	NSCLC	2.3	20628	20556	1	FALSE	NA	FALSE	NA	20792	0.1093	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2017/03	NA	0.37	Do not report	567436	7	LUAD	7.8	NA	17.5	YES	lung	20642	2.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	810	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 12p11-12, including KRAS.	Included	FALSE	NA	7	30	SOC	Yes	2017, Wk. 09	NA
lung_msk_mind_2020	P-0018078	P-0018078-T01-IM6	68	68	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	3/9/17	NA	25281	NSCLC	1.6	25108	25087	1	FALSE	NA	FALSE	NA	25281	0.1624	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	2	10	No	Liver	FALSE	NA	NA	PD1 alone	2017/03	NA	0.24	Do not report	569448	7	LUAD	6.4	NA	40	YES	lung	25121	1.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	649	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q31-44, 8q11-21, and 14q13-21. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 2q35-37, 6q15-26, 8p12-21, 10q21-23, and 12p12-13.	Included	FALSE	NA	6.1	30	SOC	Yes	2017, Wk. 10	NA
lung_msk_mind_2020	P-0018179	P-0018179-T01-IM6	69	71	3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	70	NA	CT chest	37.9	2.6	25.7	NA	3/11/17	NA	26132	NSCLC	2.5	25432	25418	1	FALSE	NA	FALSE	NA	26132	0.0764	IMPACT468	95	NOS	No	MSKCC	Resection + Ipilimumab+Nivolumab	1	80	No	Soft Tissue	TRUE	D1010H (driver)	NA	PD1+CTLA4	2017/03	NA	0.12	Do not report	573350	3	NSCLCPD	23.5	NA	20	YES	pleura	25450	1.1	1:PROGRESS	Lung	14-137	FALSE	NA	FALSE	NA	Tumor	1	893	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	2.6	50	Clinical trial	Yes	2017, Wk. 10	NA
lung_msk_mind_2020	P-0018197	P-0018197-T01-IM6	66	67	3.8	FALSE	L1044H	NO	FALSE	NA	SD	FALSE	R260C	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	98.2	48.3	99.4	NA	3/9/17	Durable clinical benefit	NA	NSCLC	2.9	24352	24274	1	TRUE	AMP (driver)	FALSE	NA	24907	0.1270	IMPACT468	70	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/03	NA	0	Do not report	569095	55	LUAD	NA	NA	17.5	YES	lung	24595	10.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	753	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	48.3	30	SOC	No	2017, Wk. 10	NA
lung_msk_mind_2020	P-0018198	P-0018198-T01-IM6	45	45	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	90	NA	CT chest	37.9	2.6	25.7	NA	3/9/17	NA	16919	NSCLC	3.8	16631	16547	1	FALSE	NA	FALSE	NA	16919	0.1061	IMPACT468	NA	Large cell neuroendocrine	Yes	MSKCC	Nivolumab	2	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2017/03	NA	0.35	Do not report	NA	3	LUNE	12.2	NA	0	NO	lymph node	16596	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	714	Metastasis	Female	Never smoker	Matched	NA	Excluded	FALSE	NA	2.6	50	SOC	Yes	2017, Wk. 10	NA
lung_msk_mind_2020	P-0018366	P-0018366-T01-IM6	48	48	4.3	FALSE	NA	NO	TRUE	Q766Sfs*67 (driver)	PR	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	20	NA	CT chest	89.7	12.3	82.3	NA	3/15/17	NA	18408	NSCLC	0.9	18403	17681	1	FALSE	NA	FALSE	NA	18408	0.1182	IMPACT468	60	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	30	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2017/03	NA	0.3	Do not report	575986	14	NSCLCPD	23.9	NA	15	YES	lymph node	17858	5.8	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	396	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	12.3	30	SOC	Yes	2017, Wk. 11	NA
lung_msk_mind_2020	P-0018511	P-0018511-T01-IM6	74	75	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	50	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	Cytolyt	3/21/17	NA	27189	NSCLC	7.4	27132	27132	2	FALSE	NA	FALSE	NA	27189	0.2762	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	80	No	Lymph Node	TRUE	D1228H (driver)	NA	PD1 alone	2017/03	NA	2.67	Do not report	578752	10	LUAD	1.9	NA	30	YES	lymph node	27170	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	777	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	8.8	40	SOC	Yes	2017, Wk. 12	NA
lung_msk_mind_2020	P-0018517	P-0018517-T01-IM6	80	80	4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	3/21/17	No durable clinical benefit	29356	NSCLC	3.6	29314	29286	1	FALSE	NA	FALSE	NA	29356	0.1755	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2017/03	NA	0.07	Do not report	581781	7	LUAD	2.3	NA	80	YES	lung	29356	2.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	788	Primary	Male	Former smoker	Matched	NA	Included	TRUE	E256* (driver)	6.1	30	SOC	Yes	2017, Wk. 12	NA
lung_msk_mind_2020	P-0018557	P-0018557-T01-IM6	83	83	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	3/21/17	NA	30573	NSCLC	1.7	30538	30524	1	FALSE	NA	FALSE	NA	30573	0.2191	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	5	No	Liver	FALSE	NA	NA	PD1 alone	2017/03	NA	0.34	Do not report	579607	10	LUAD	1.6	NA	50	YES	liver	30561	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	771	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	8.8	30	SOC	Yes	2017, Wk. 12	NA
lung_msk_mind_2020	P-0018599	P-0018599-T01-IM6	63	63	3.7	FALSE	NA	NO	TRUE	D1850Tfs*33 (driver)	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest	97.4	38.6	98.7	NA	3/23/17	NA	23089	NSCLC	30.2	23053	23053	1	FALSE	NA	FALSE	NA	23089	0.2340	IMPACT468	NA	Squamous	No	MSKCC	Pembrolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/03	MICROSATELLITE INSTABILITY-HIGH (MSI-H). This result is for investigational use only. See MSI note below.	11.35	Instable	582712	43	NSCLC	1.2	NA	42.5	YES	chest wall	23089	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	940	Primary	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 3q26.33-q28. Note: High proportion of G>T / C>A transversions is suggestive of smoking-induced DNA damage.	Excluded	FALSE	NA	38.6	40	SOC	Yes	2017, Wk. 12	NA
lung_msk_mind_2020	P-0018722	P-0018722-T01-IM6	44	44	3.6	FALSE	NA	NO	FALSE	NA	PR	TRUE	V600E (driver)	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	70	NA	CT chest/abdomen/pelvis	94.1	19.3	93.4	NA	3/25/17	NA	NA	NSCLC	6.8	16855	16196	1	FALSE	NA	FALSE	NA	16859	0.1774	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	3	60	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/03	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.09	Stable	NA	20	NSCLC	NA	NA	31.5	NO	lymph node	16768	18.8	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	887	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	19.3	30	SOC	No	2017, Wk. 12	NA
lung_msk_mind_2020	P-0018763	P-0018763-T01-IM6	83	82	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	50	NA	CT chest	0	0	0	NA	3/28/17	NA	NA	NSCLC	2.7	30444	30360	2	FALSE	NA	FALSE	NA	30750	0.0000	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	50	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/03	NA	NA	NA	587326	NA	LUAD	NA	NA	40	YES	lymph node	30421	2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1181	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 10% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	0	10	SOC	No	2017, Wk. 13	NA
lung_msk_mind_2020	P-0018820	P-0018820-T01-IM6	61	62	4	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	89.2	11.4	81.4	NA	3/30/17	Durable clinical benefit	NA	NSCLC	2.2	22863	22391	1	FALSE	NA	FALSE	NA	23318	0.3416	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	NA	NA	Lung	FALSE	NA	NA	PD1 alone	2017/03	NA	0.83	Do not report	491081	13	LUAD	NA	NA	21	YES	lung	22888	16.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1009	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Excluded	FALSE	NA	11.4	30	SOC	No	2017, Wk. 13	NA
lung_msk_mind_2020	P-0018960	P-0018960-T01-IM6	59	60	3.6	FALSE	NA	NO	FALSE	NA	POD/bone	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	10	NA	CT chest/abdomen/pelvis	86.6	10.5	76.9	NA	4/4/17	NA	21802	NSCLC	4.2	21755	21755	1	FALSE	NA	FALSE	NA	21802	0.0636	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	0	No	Rib	FALSE	NA	NA	PD1 alone	2017/04	NA	-1	Do not report	583670	12	LUAD	1.5	NA	10	YES	soft tissue (rib)	21775	0.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	A1459V	Tumor	1	746	Metastasis	Female	Former smoker	Unmatched	NA	Included	TRUE	E70* (driver)	10.5	40	SOC	Yes	2017, Wk. 14	NA
lung_msk_mind_2020	P-0018979	P-0018979-T01-IM6	64	64	4.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	60	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	4/4/17	NA	23657	NSCLC	3.2	23547	23526	1	FALSE	NA	TRUE	Y772_A775dup (driver)	23657	0.0000	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Pembrolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/04	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	588905	3	NSCLC	4.3	NA	0	YES	lymph node	23568	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	734	Primary	Female	Never smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	Excluded	FALSE	NA	2.6	10	SOC	Yes	2017, Wk. 14	NA
lung_msk_mind_2020	P-0019098	P-0019098-T01-IM6	56	56	3.9	FALSE	G1473E	NO	FALSE	NA	SD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	95.6	26.3	96.9	SSL	4/13/17	Durable clinical benefit	NA	NSCLC	4.1	21088	20740	1	FALSE	NA	FALSE	NA	21181	0.0457	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/04	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	591939	30	LUAD	NA	NA	14.4	YES	lymph node	21105	12	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	705	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	D176Tfs*111 (driver)	26.3	20	SOC	No	2017, Wk. 15	NA
lung_msk_mind_2020	P-0019252	P-0019252-T03-IM6	73	74	3.8	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	91	13.2	85.8	NA	9/26/17	NA	27094	NSCLC	1.7	26853	26829	1	FALSE	NA	FALSE	NA	27094	0.2264	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.26	Stable	610690	15	LUAD	8.7	NA	0.25	YES	lung	26893	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	466	Primary	Female	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q22-44 (including NTRK1 and AKT3). Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 1p12-34.1.	Excluded	FALSE	A241P	13.2	30	SOC	Yes	2017, Wk. 39	NA
lung_msk_mind_2020	P-0019262	P-0019262-T02-IM6	53	55	4.2	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	0	NA	CT chest/abdomen/pelvis	96.7	33.4	98	NA	10/7/17	NA	19881	NSCLC	4.6	19813	19704	1	FALSE	NA	FALSE	NA	19881	0.5640	IMPACT468	NA	Large cell neuroendocrine	Yes	MSKCC	Atezolizumab	2	0	No	Brain	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	5.23	Indeterminate	725805	38	LUNE	5.8	NA	15	YES	brain	19828	4.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	456	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	TRUE	P281Rfs*6 (driver)	33.4	60	SOC	Yes	2017, Wk. 40	NA
lung_msk_mind_2020	P-0019298	P-0019298-T01-IM6	83	84	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	90	NA	CT chest	89.2	11.4	81.4	NA	4/30/17	NA	30755	NSCLC	2.5	30656	30614	1	FALSE	NA	FALSE	NA	30755	0.2029	IMPACT468	NA	NOS	Yes	MSKCC	Pembrolizumab	1	90	NA	NA	FALSE	NA	NA	PD1 alone	2017/04	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.56	Stable	598961	13	NSCLC	4.6	NA	6	YES	lung	30656	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	621	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	11.4	60	SOC	Yes	2017, Wk. 17	NA
lung_msk_mind_2020	P-0019390	P-0019390-T01-IM6	69	69	4.1	FALSE	A207Qfs*42	YES	TRUE	Q1098* (driver)	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	30	NA	CT chest/abdomen/pelvis	98.2	49.2	99.5	NA	4/25/17	NA	25761	NSCLC	1.5	25480	25312	0	FALSE	NA	FALSE	NA	25761	0.3430	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	30	No	Adrenal	FALSE	NA	NA	PD1 alone	2017/04	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.43	Stable	598973	56	LUAD	14.8	NA	42	YES	adrenal	25371	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	986	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	49.2	60	SOC	Yes	2017, Wk. 17	NA
lung_msk_mind_2020	P-0019599	P-0019599-T01-IM6	73	74	2.5	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	97.7	42.1	99.1	NA	5/4/17	NA	26981	NSCLC	1.6	26965	26965	2	TRUE	L858R (driver)	TRUE	G660D (driver)	26981	0.2677	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	80	No	Duodenum	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE INSTABILITY-HIGH (MSI-H). This result is for investigational use only. See MSI note below.	27.99	Instable	603039	48	LUAD	0.5	NA	14	YES	duodenum	26981	0.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	873	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	42.1	50	SOC	Yes	2017, Wk. 18	NA
lung_msk_mind_2020	P-0019605	P-0019605-T02-IM6	67	68	3.9	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Lung Squamous Cell Carcinoma	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	90.8	13.2	86.2	NA	8/17/17	NA	24693	NSCLC	8.7	24669	24669	1	FALSE	NA	FALSE	NA	24693	0.4351	IMPACT468	NA	Squamous	Yes	MSKCC	Atezolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	1.18	Stable	673181	14	LUSC	0.8	NA	12.5	YES	chest wall	24693	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	S1626Y	Tumor	1	689	Unknown	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	13.2	40	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0019607	P-0019607-T02-IM6	76	80	3.7	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	1/30/18	NA	NA	NSCLC	1.9	28288	27931	1	FALSE	NA	TRUE	L755F (driver)	29609	0.0906	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Durvalumab	3	NA	NA	NA	TRUE	X1010_splice (driver)	NA	PD1 alone	2018/01	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	NA	7	LUAD	NA	NA	0	NO	lung	28678	24.5	1:PROGRESS	Lung	14-103	FALSE	NA	FALSE	NA	Tumor	1	1062	Primary	Male	Never smoker	Matched	NA	Excluded	FALSE	NA	6.1	20	Clinical trial	No	2018, Wk. 05	NA
lung_msk_mind_2020	P-0019647	P-0019647-T01-IM6	53	52	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	5/2/17	NA	NA	NSCLC	1	19655	19457	1	FALSE	NA	FALSE	NA	19926	0.0968	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	606875	5	LUAD	NA	NA	0	YES	lung	19514	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	907	Primary	Male	Never smoker	Matched	NA	Excluded	FALSE	NA	4.4	20	SOC	No	2017, Wk. 18	NA
lung_msk_mind_2020	P-0019700	P-0019700-T01-IM6	81	81	3.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	92.5	15.8	89.7	NA	5/6/17	Durable clinical benefit	NA	NSCLC	1.2	30282	29680	1	FALSE	NA	FALSE	NA	30555	0.0147	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Atezolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	NA	18	LUAD	NA	NA	49	NO	lung	30296	20.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	765	Primary	Female	Former smoker	Matched	NA	Excluded	FALSE	NA	15.8	30	SOC	No	2017, Wk. 18	NA
lung_msk_mind_2020	P-0019765	P-0019765-T02-IM6	56	58	4.5	FALSE	NA	YES	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	94.6	21.1	94.4	Formalin	6/5/18	Durable clinical benefit	NA	NSCLC	3.3	20814	20772	1	FALSE	NA	FALSE	NA	21262	0.5899	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	0	NA	Lymph node	FALSE	NA	NA	PD1 alone	2018/06	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.28	Indeterminate	NA	24	LUAD	NA	NA	12.5	NO	lymph node	21161	12.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1005	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Excluded	FALSE	NA	21.1	60	SOC	No	2018, Wk. 23	NA
lung_msk_mind_2020	P-0019804	P-0019804-T02-IM6	69	73	4.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	15	NA	CT chest/abdomen/pelvis	76.6	7	60.3	NA	7/6/17	Durable clinical benefit	NA	NSCLC	0.8	25595	25259	1	FALSE	NA	FALSE	NA	26938	0.0364	IMPACT468	90	Adenocarcinoma	No	MSKCC	Durvalumab	2	20	No	NA	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.18	Stable	641527	8	LUAD	NA	NA	14	YES	lung	25651	12.9	1:PROGRESS	Lung	12-179	FALSE	NA	FALSE	NA	Tumor	1	806	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	7	30	Clinical trial	No	2017, Wk. 27	NA
lung_msk_mind_2020	P-0019914	P-0019914-T02-IM6	68	68	3.9	FALSE	NA	NO	TRUE	Q611* (driver)	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	6/6/17	NA	NA	NSCLC	2	25025	24959	1	FALSE	NA	FALSE	NA	25350	0.1886	IMPACT468	60	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	0	No	Adrenal Gland	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.12	Stable	600774	9	LUAD	NA	NA	10	YES	adrenal	25050	3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1025	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	7.9	60	SOC	No	2017, Wk. 23	NA
lung_msk_mind_2020	P-0020011	P-0020011-T01-IM6	79	81	3.8	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	95	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	5/20/17	NA	29683	NSCLC	5.1	29356	29042	1	FALSE	NA	FALSE	NA	29683	0.3656	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	NA	NA	Soft Tissue	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.67	Stable	616792	9	LUAD	21.1	NA	25	YES	soft tissue (L2)	29657	20.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	821	Metastasis	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	7.9	60	SOC	Yes	2017, Wk. 20	NA
lung_msk_mind_2020	P-0020076	P-0020076-T02-IM6	62	63	3.8	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	44.1	3.5	30.4	NA	6/16/17	NA	NA	NSCLC	1.8	22982	22807	1	TRUE	L858R (driver)	FALSE	NA	23310	0.2061	IMPACT468	NA	Adenosquamous	Yes	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.25	Stable	618852	4	LUAD	NA	NA	47	YES	lung	22875	2.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	866	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	3.5	50	SOC	No	2017, Wk. 24	NA
lung_msk_mind_2020	P-0020140	P-0020140-T02-IM6	72	74	3.7	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	50	NA	CT chest/abdomen/pelvis	85.8	9.7	75.5	NA	8/17/17	NA	26751	NSCLC	1.4	26630	26584	1	FALSE	NA	FALSE	NA	26751	0.0045	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	NA	NA	Soft Tissue	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	670341	11	LUAD	5.5	NA	165	YES	lymph node	26655	2.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	425	Metastasis	Male	Former smoker	Matched	This sample has been nominated for further analysis using the Archer targeted RNAseq assay. Assay will be performed if additional material is available and results will be reported under a separate accession number.	Excluded	TRUE	E138Rfs*20 (driver)	9.7	70	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0020192	P-0020192-T01-IM6	66	67	2.8	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	5/25/17	NA	24380	NSCLC	7.1	24298	24298	1	TRUE	AMP (driver), L861Q (driver)	FALSE	NA	24380	0.0348	IMPACT468	NA	NOS	Yes	MSKCC	Nivolumab	3	0	No	Lymph node	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	607843	11	LUAD	2.7	NA	21	YES	lymph node	24310	0.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	396	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	9.7	30	SOC	Yes	2017, Wk. 21	NA
lung_msk_mind_2020	P-0020347	P-0020347-T01-IM6	53	55	3.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	44.1	3.5	30.4	NA	5/31/17	NA	19732	NSCLC	1.9	19634	19612	1	FALSE	NA	FALSE	NA	19732	0.0892	IMPACT468	50	Adenocarcinoma	No	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/05	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	621905	4	LUAD	3.9	NA	10	YES	bone	19658	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	494	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	X199_splice (driver)	3.5	60	SOC	Yes	2017, Wk. 22	NA
lung_msk_mind_2020	P-0020422	P-0020422-T01-IM6	67	68	3.8	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest	95.7	27.2	97	NA	6/6/17	NA	24628	NSCLC	2.1	24560	24539	1	FALSE	NA	FALSE	NA	24628	0.0443	IMPACT468	70	Adenocarcinoma	Yes	MSKCC	Atezolizumab	3	1	Yes	NA	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.14	Stable	553675	31	LUAD	2.9	NA	12.25	YES	lung	24581	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	855	Unknown	Female	Former smoker	Matched	NA	Included	TRUE	E138* (driver)	27.2	20	SOC	Yes	2017, Wk. 23	NA
lung_msk_mind_2020	P-0020643	P-0020643-T01-IM6	65	66	3.9	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	10	NA	CT chest/abdomen/pelvis	92.8	16.7	90.4	NA	6/15/17	NA	NA	NSCLC	3.9	24315	23735	1	FALSE	NA	FALSE	NA	24502	0.0323	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	10	No	Adrenal Gland	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.18	Stable	634203	18	NSCLCPD	NA	NA	40	YES	adrenal	24008	9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	674	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	16.7	60	SOC	No	2017, Wk. 24	NA
lung_msk_mind_2020	P-0020755	P-0020755-T01-IM6	63	65	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	75	NA	CT chest	73.7	6.1	56.8	NA	6/19/17	NA	23777	NSCLC	2	23236	23215	1	FALSE	NA	FALSE	NA	23777	0.2580	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	50	Yes	NA	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.8	Stable	488600	7	NSCLC	18.5	NA	60	YES	adrenal	23256	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	700	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	6.1	60	SOC	Yes	2017, Wk. 25	NA
lung_msk_mind_2020	P-0021034	P-0021034-T01-IM6	73	75	3.5	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest	79.1	7.9	63.8	NA	6/28/17	NA	NA	NSCLC	6.9	27101	26922	1	FALSE	NA	FALSE	R929Q	27767	0.0392	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	No	NA	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.32	Stable	624007	9	LUAD	NA	NA	48	YES	pleura	27245	10.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	716	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	7.9	20	SOC	No	2017, Wk. 26	NA
lung_msk_mind_2020	P-0021094	P-0021094-T01-IM6	69	70	3.6	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	Cytolyt	6/29/17	NA	25439	NSCLC	6	25420	25384	1	FALSE	NA	FALSE	NA	25439	0.0040	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/06	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	646162	6	NSCLC	1.8	NA	45	YES	lymph node	25420	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	783	Metastasis	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	TRUE	L282Sfs*5 (driver)	5.3	20	SOC	Yes	2017, Wk. 26	NA
lung_msk_mind_2020	P-0021112	P-0021112-T01-IM6	78	80	3.1	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	90	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	7/7/17	NA	29375	NSCLC	6.5	28868	28629	1	FALSE	NA	FALSE	NA	29375	0.5186	IMPACT468	NA	NOS	Yes	MSKCC	Pembrolizumab	1	NA	NA	NA	FALSE	MET-intragenic - Archer	NA	PD1 alone	2017/07	MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.	3.02	Indeterminate	620887	9	NSCLC	24.5	NA	0	YES	lung	28881	8.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	884	Primary	Female	Never smoker	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Excluded	FALSE	NA	8.8	60	SOC	Yes	2017, Wk. 27	NA
lung_msk_mind_2020	P-0021231	P-0021231-T01-IM6	55	55	3.6	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	5	NA	CT chest/abdomen/pelvis	76.6	7	60.3	NA	7/4/17	NA	20172	NSCLC	2.5	20122	20059	1	FALSE	NA	FALSE	NA	20172	0.4055	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	5	No	Abdomen	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.61	Stable	653182	8	LUSC	3.7	NA	75	YES	soft tissue (abdomen)	20122	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	700	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	7	60	SOC	Yes	2017, Wk. 27	NA
lung_msk_mind_2020	P-0021266	P-0021266-T01-IM6	54	55	4.3	FALSE	NA	YES	FALSE	NA	CR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	95	23.7	96.1	NA	7/7/17	NA	20308	NSCLC	10	20140	19739	1	FALSE	NA	FALSE	NA	20308	0.3556	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	5	No	Brain	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.98	Stable	644978	27	LUAD	18.7	NA	7.5	YES	brain	20022	9.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	503	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	K84* (driver)	23.7	40	SOC	Yes	2017, Wk. 27	NA
lung_msk_mind_2020	P-0021291	P-0021291-T01-IM6	56	57	3.8	FALSE	NA	NO	TRUE	E1032* (driver)	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest/abdomen/pelvis	94.1	19.3	93.3	NA	7/11/17	NA	NA	NSCLC	1.6	21409	20732	1	FALSE	NA	FALSE	NA	21425	0.1610	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	10	No	Adrenal	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.36	Stable	566290	22	LUAD	NA	NA	45	YES	adrenal	21425	22.8	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	761	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	19.3	30	SOC	No	2017, Wk. 28	NA
lung_msk_mind_2020	P-0021375	P-0021375-T01-IM6	68	70	3.4	FALSE	NA	YES	TRUE	S711* (driver)	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	7/11/17	NA	25191	NSCLC	2.3	25175	25161	1	FALSE	NA	FALSE	NA	25191	0.0931	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Bone	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.41	Stable	653290	7	NSCLC	1	NA	0.5	YES	bone	25191	1	1:PROGRESS	Lung	NA	FALSE	P181S	FALSE	NA	Tumor	1	721	Metastasis	Male	Former smoker	Matched	This sample has been nominated for further analysis using the Archer targeted RNAseq assay as an apparent driver-negative cancer. Assay will be performed if additional material is available and results will be reported under a separate accession number.	Included	FALSE	STK11-intragenic	6.1	30	SOC	Yes	2017, Wk. 28	NA
lung_msk_mind_2020	P-0021442	P-0021442-T01-IM6	66	67	3.4	FALSE	NA	YES	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	87.1	10.5	77	Cytolyt	7/11/17	NA	24264	NSCLC	1.6	24241	24187	1	FALSE	NA	FALSE	NA	24264	0.5208	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Lymph node	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.83	Stable	651077	12	LUAD	2.5	NA	58	YES	lymph node	24243	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	977	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	X200_splice (driver)	10.5	40	SOC	Yes	2017, Wk. 28	NA
lung_msk_mind_2020	P-0021470	P-0021470-T01-IM6	47	49	3.8	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	70	NA	CT chest	87.1	10.5	77	NA	7/14/17	NA	17866	NSCLC	2.5	17463	17402	0	FALSE	NA	FALSE	NA	17866	0.0805	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	70	No	Brain	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.2	Stable	582735	11	LUAD	15.2	NA	28	YES	lung	17479	2.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	611	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	10.5	20	SOC	Yes	2017, Wk. 28	NA
lung_msk_mind_2020	P-0021696	P-0021696-T01-IM6	69	71	3.2	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	7/27/17	NA	25532	NSCLC	1.8	25491	25449	2	FALSE	NA	FALSE	NA	25532	0.1051	IMPACT468	80	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	665484	10	NSCLC	2.7	NA	unk	YES	lymph node	25498	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	602	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	TRUE	X97_splice (driver)	8.8	70	SOC	Yes	2017, Wk. 30	NA
lung_msk_mind_2020	P-0021769	P-0021769-T01-IM6	NA	75	NA	NA	NA	YES	NA	NA	NA	NA	NA	Cancer of Unknown Primary	Cancer of Unknown Primary, NOS	NA	NA	NA	99.2	75.5	99	NA	7/29/17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1902	IMPACT468	NA	NA	NA	MSKCC	NA	NA	NA	NA	Lymph node	NA	NA	NA	NA	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.38	Stable	666068	85	CUPNOS	NA	NA	NA	YES	NA	NA	NA	NA	Unknown	NA	NA	NA	NA	NA	Tumor	1	868	Metastasis	NA	NA	Matched	NA	NA	NA	NA	NA	70	NA	NA	2017, Wk. 30	NA
lung_msk_mind_2020	P-0021797	P-0021797-T01-IM6	38	40	4.2	FALSE	NA	NO	FALSE	NA	CR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest	44.1	3.5	30.4	NA	7/29/17	NA	NA	NSCLC	1.2	14310	14142	1	FALSE	NA	TRUE	Y772_A775dup (driver)	14954	0.0384	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	60	No	NA	FALSE	NA	NA	PD1 alone	2017/07	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	658648	4	LUAD	NA	NA	13.5	YES	lung	14700	18.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	649	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	3.5	20	SOC	No	2017, Wk. 30	NA
lung_msk_mind_2020	P-0021833	P-0021833-T01-IM6	65	67	4.3	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen	91.4	14	86.9	NA	8/1/17	NA	NA	NSCLC	1.9	24476	23992	1	FALSE	NA	FALSE	NA	24749	0.5585	IMPACT468	60	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	0	No	Liver	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.29	Stable	665530	16	LUAD	NA	NA	0	YES	liver	24299	10.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	S66C	Tumor	1	720	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	14	10	SOC	No	2017, Wk. 31	NA
lung_msk_mind_2020	P-0022001	P-0022001-T01-IM6	67	68	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	38.1	2.6	25.9	NA	8/17/17	NA	24896	NSCLC	7.5	24715	24694	1	FALSE	NA	FALSE	NA	24896	0.0777	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Pleura	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	674367	3	LUAD	6.6	NA	0	YES	pleura	24732	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	880	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	2.6	20	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022011	P-0022011-T01-IM6	80	81	3.4	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	5	NA	CT chest	89.7	12.3	82.3	NA	8/17/17	NA	29735	NSCLC	2.2	29607	29313	1	FALSE	NA	FALSE	NA	29735	0.1135	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	5	No	Adrenal Gland	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	670301	14	LUAD	13.9	NA	61.5	YES	adrenal	29542	7.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	567	Metastasis	Male	Former smoker	Matched	This sample has been nominated for further analysis using the Archer targeted RNAseq assay. Assay will be performed if additional material is available and results will be reported under a separate accession number.	Included	TRUE	P281Rfs*6 (driver)	12.3	30	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022033	P-0022033-T01-IM6	71	72	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	73.7	6.1	56.8	NA	8/17/17	NA	26371	NSCLC	1.5	26149	26127	1	FALSE	NA	FALSE	NA	26371	0.3485	IMPACT468	95	Squamous	Yes	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	670324	7	LUSC	8	NA	55	YES	soft tissue (iliac)	26149	0.7	1:PROGRESS	Lung	NA	FALSE	W324R	FALSE	NA	Tumor	1	858	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	6.1	30	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022103	P-0022103-T01-IM6	72	72	3.7	FALSE	NA	NO	TRUE	Q372Afs*28 (driver)	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	70	NA	CT chest	54.1	4.4	38.5	NA	8/17/17	NA	NA	NSCLC	1.2	26405	26301	0	TRUE	AMP (driver)	FALSE	NA	26557	0.2535	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	80	No	NA	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	675548	5	LUAD	NA	NA	15	YES	lung	26378	2.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	853	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	4.4	20	SOC	No	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022291	P-0022291-T02-IM6	68	69	3.9	FALSE	NA	NO	FALSE	NA	POD	TRUE	G469A (driver)	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	1	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	3/28/18	NA	25387	NSCLC	1.5	25182	25140	1	FALSE	NA	FALSE	NA	25387	0.1481	IMPACT468	95	Large Cell	Yes	MSKCC	Atezolizumab	1	5	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	986123	9	LUNE	8.1	NA	147	YES	lung	25201	2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	913	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	TRUE	X200_splice (driver)	7.9	20	SOC	Yes	2018, Wk. 13	NA
lung_msk_mind_2020	P-0022301	P-0022301-T01-IM6	76	77	3	FALSE	NA	NO	FALSE	NA	POD/bone	FALSE	V487L	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	1	NA	CT chest/abdomen/pelvis	93.7	18.4	92.4	NA	8/18/17	NA	28093	NSCLC	2	28038	27975	1	FALSE	NA	FALSE	NA	28093	0.1102	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	1	No	NA	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	684104	21	NSCLCPD	3.9	NA	30	YES	lung	28052	2.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	604	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	18.4	10	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022304	P-0022304-T01-IM6	71	72	4.1	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	13.1	0.9	7.8	Cytolyt	8/17/17	NA	26722	NSCLC	1.5	26334	26215	1	FALSE	NA	FALSE	NA	26722	0.0036	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	671597	1	LUAD	16.7	NA	75	YES	lymph node	26337	4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	854	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Excluded	FALSE	NA	0.9	20	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022377	P-0022377-T01-IM6	63	65	3.6	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest	25.2	1.8	16.1	NA	8/17/17	NA	23486	NSCLC	1.9	23375	23333	1	FALSE	NA	FALSE	NA	23486	0.2469	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	50	No	NA	FALSE	NA	NA	PD1 alone	2017/08	MICROSATELLITE STABLE (MSS). See MSI note below.	1.51	Stable	686680	2	NSCLC	5	NA	38.7	YES	lung	23392	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	787	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	1.8	20	SOC	Yes	2017, Wk. 33	NA
lung_msk_mind_2020	P-0022808	P-0022808-T01-IM6	75	76	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	9/6/17	NA	27782	NSCLC	4.7	27738	27673	1	FALSE	NA	FALSE	NA	27782	0.3906	IMPACT468	80	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	1	Yes	Bone	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.45	Stable	687852	6	LUAD	3.6	NA	0	YES	bone	27758	2.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	653	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	5.3	20	SOC	Yes	2017, Wk. 36	NA
lung_msk_mind_2020	P-0022949	P-0022949-T01-IM6	61	62	3.7	FALSE	NA	NO	FALSE	NA	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen	82.2	8.8	68.4	NA	9/15/17	NA	NA	NSCLC	2.3	22305	22284	1	FALSE	NA	FALSE	NA	22433	0.0022	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	1	80	No	NA	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	620874	10	LUAD	NA	NA	46	YES	lung	22367	2.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	423	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	8.8	10	SOC	No	2017, Wk. 37	NA
lung_msk_mind_2020	P-0023014	P-0023014-T01-IM6	69	70	3.5	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	Cytolyt	9/22/17	NA	25328	NSCLC	4.8	25289	25289	1	FALSE	NA	FALSE	NA	25328	0.3095	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	691829	5	LUAD	1.3	NA	15	YES	lymph node	25328	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	830	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	R103_R104del	4.4	40	SOC	Yes	2017, Wk. 38	NA
lung_msk_mind_2020	P-0023023	P-0023023-T01-IM6	63	64	4.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	1	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	Cytolyt	9/19/17	Durable clinical benefit	NA	NSCLC	2.9	23311	23059	1	FALSE	NA	FALSE	NA	23824	0.0205	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	TRUE	AMP (driver), D1010Y (driver)	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	421633	9	LUAD	NA	NA	12	YES	lymph node	23315	8.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	689	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	7.9	30	SOC	No	2017, Wk. 38	NA
lung_msk_mind_2020	P-0023260	P-0023260-T01-IM6	79	80	3.5	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	9/27/17	No durable clinical benefit	29112	NSCLC	4.3	29079	29065	1	FALSE	NA	FALSE	NA	29112	0.1423	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	713380	6	LUAD	1.5	NA	20	YES	lung	29112	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	538	Primary	Male	Former smoker	Matched	NA	Excluded	TRUE	K62* (driver)	5.3	40	SOC	Yes	2017, Wk. 39	NA
lung_msk_mind_2020	P-0023408	P-0023408-T01-IM6	64	65	3.5	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	10/4/17	NA	23572	NSCLC	3.7	23543	23543	2	FALSE	NA	FALSE	NA	23572	0.4437	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	1.38	Stable	722792	11	LUAD	1	NA	17.6	YES	lymph node	23572	1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	X833_splice	Tumor	1	402	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 3p21.	Included	TRUE	R28Pfs*135 (driver)	9.7	50	SOC	Yes	2017, Wk. 40	NA
lung_msk_mind_2020	P-0023464	P-0023464-T01-IM6	79	80	3.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	10/6/17	No durable clinical benefit	29306	NSCLC	3.5	29189	29049	2	FALSE	NA	FALSE	NA	29306	0.1313	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.64	Stable	560849	11	LUAD	8.4	NA	33	YES	pleura	29211	5.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	891	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	9.7	30	SOC	Yes	2017, Wk. 40	NA
lung_msk_mind_2020	P-0023562	P-0023562-T01-IM6	70	71	4.2	FALSE	NA	YES	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	70	NA	CT chest/abdomen	13.1	0.9	7.8	NA	10/8/17	Durable clinical benefit	26197	NSCLC	2.1	26021	25776	1	FALSE	NA	FALSE	NA	26197	0.0098	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	70	No	Adrenal	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	722865	1	LUAD	13.8	NA	2.25	YES	adrenal	26197	13.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	356	Metastasis	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Note:This sample has been nominated for further analysis usi	Included	FALSE	NA	0.9	10	SOC	Yes	2017, Wk. 40	NA
lung_msk_mind_2020	P-0023568	P-0023568-T01-IM6	67	68	3.3	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	10	NA	CT chest/abdomen/pelvis	95.4	24.6	96	NA	10/9/17	NA	24787	NSCLC	33.1	24759	24759	1	FALSE	NA	FALSE	NA	24787	0.3966	IMPACT468	NA	Giant Cell	Yes	MSKCC	Pembrolizumab	2	NA	NA	Soft Tissue	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	1.55	Stable	723652	28	NSCLCPD	0.9	NA	15	YES	soft tissue (thigh)	24787	0.9	1:PROGRESS	Lung	NA	FALSE	R231L	FALSE	NA	Tumor	1	665	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Excluded	TRUE	L282Afs*3 (driver)	24.6	80	SOC	Yes	2017, Wk. 41	NA
lung_msk_mind_2020	P-0023596	P-0023596-T01-IM6	62	63	3.7	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	73.7	6.1	56.8	Formalin	10/31/17	NA	23015	NSCLC	1	22968	22940	1	TRUE	H773dup (driver)	FALSE	NA	23015	0.3988	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/10	NA	1.98	Do not report	NA	7	LUAD	2.5	NA	0.5	NO	lymph node	22982	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	145	Metastasis	Male	Former smoker	Matched	Note: Assessment of the copy number profile is limited by increased background noise. False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Included	FALSE	NA	6.1	30	SOC	Yes	2017, Wk. 44	NA
lung_msk_mind_2020	P-0023598	P-0023598-T01-IM6	67	68	3.5	FALSE	G2R	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	30	NA	CT chest/abdomen/pelvis	92.3	14.9	89.1	Cytolyt	10/31/17	NA	NA	NSCLC	0.5	24676	24676	1	FALSE	NA	FALSE	NA	25366	0.1282	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	50	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.26	Stable	726229	17	LUAD	NA	NA	20	YES	lymph node	24786	3.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	L1665Ffs*7	Tumor	1	744	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	14.9	30	SOC	No	2017, Wk. 44	NA
lung_msk_mind_2020	P-0023779	P-0023779-T01-IM6	74	75	3.2	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	0	NA	CT chest/abdomen/pelvis	82.2	8.8	68.4	NA	10/18/17	No durable clinical benefit	27316	NSCLC	0.9	27287	27266	1	FALSE	A120G	FALSE	NA	27316	0.1124	IMPACT468	95	NOS	Yes	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.63	Stable	718414	10	NSCLC	1.6	NA	17.25	YES	lung	27316	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	488	Primary	Male	Former smoker	Matched	NA	Included	TRUE	K44* (driver)	8.8	40	SOC	Yes	2017, Wk. 42	NA
lung_msk_mind_2020	P-0023902	P-0023902-T01-IM6	52	54	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	10/22/17	NA	19464	NSCLC	0.6	19292	19250	1	TRUE	L747P (driver)	FALSE	NA	19464	0.4111	IMPACT468	NA	Adenocarcinoma	No	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	1.41	Stable	738586	3	LUAD	7	NA	0	YES	bone	19305	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	501	Primary	Female	Never smoker	Matched	NA	Included	FALSE	NA	2.6	50	SOC	Yes	2017, Wk. 42	NA
lung_msk_mind_2020	P-0023926	P-0023926-T01-IM6	69	69	2.8	FALSE	NA	YES	FALSE	NA	POD/death	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	10	NA	CT chest/abdomen/pelvis	61.9	5.3	45.8	NA	10/25/17	NA	25253	NSCLC	2.6	25229	25229	1	FALSE	NA	FALSE	NA	25253	0.4219	IMPACT468	95	NOS	Yes	MSKCC	Pembrolizumab	2	10	No	Liver	FALSE	NA	NA	PD1 alone	2017/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.64	Stable	751121	6	LUAD	0.8	NA	unk	YES	liver	25253	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	733	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: This sample is being considered for further analysis using the Archer targeted RNAseq assay for detection of gene fusion transcript, as an apparent driver-negative cancer case. Assay will be performed if additional material is available and results 	Included	FALSE	NA	5.3	30	SOC	Yes	2017, Wk. 43	NA
lung_msk_mind_2020	P-0024421	P-0024421-T02-IM6	54	55	4.2	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest	76.6	7	60.3	NA	12/2/17	NA	20042	NSCLC	1.2	19973	19910	1	FALSE	NA	FALSE	NA	20042	0.0050	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	NA	NA	NA	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	740707	8	LUAD	4.3	NA	49.5	YES	lung	19956	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	647	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative, MSIsensor, copy number and structural variant results should be interpreted with caution. Additional mutations may not be detected due to low tumor purity.	Excluded	FALSE	NA	7	20	SOC	Yes	2017, Wk. 48	NA
lung_msk_mind_2020	P-0024467	P-0024467-T01-IM6	76	77	3.8	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest	63.5	5.3	46.4	SSL	11/14/17	NA	NA	NSCLC	1.3	28268	27827	1	FALSE	NA	FALSE	NA	28538	0.1465	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	80	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/11	MICROSATELLITE STABLE (MSS). See MSI note below.	0.2	Stable	754620	6	LUAD	NA	NA	56	YES	lymph node	28059	7.6	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	828	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	5.3	40	SOC	No	2017, Wk. 46	NA
lung_msk_mind_2020	P-0024561	P-0024561-T01-IM6	68	69	4.1	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	11/17/17	NA	25198	NSCLC	2.4	25082	24991	1	FALSE	NA	FALSE	NA	25198	0.2434	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	4	0	No	NA	FALSE	NA	NA	PD1 alone	2017/11	MICROSATELLITE STABLE (MSS). See MSI note below.	0.78	Stable	758515	2	LUAD	6.8	NA	0	YES	lung	25092	3.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	790	Primary	Female	Never smoker	Matched	NA	Included	TRUE	Y253Gfs*15 (driver)	1.8	40	SOC	Yes	2017, Wk. 46	NA
lung_msk_mind_2020	P-0024764	P-0024764-T01-IM6	74	74	3.8	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	89.7	12.3	82.3	Cytolyt	11/23/17	No durable clinical benefit	NA	NSCLC	1.8	27095	27011	1	FALSE	NA	FALSE	NA	27459	0.1055	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Lymph node	FALSE	NA	NA	PD1 alone	2017/11	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	745092	14	LUAD	NA	NA	50	YES	lymph node	27167	5.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	692	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	12.3	20	SOC	No	2017, Wk. 47	NA
lung_msk_mind_2020	P-0024980	P-0024980-T03-IM6	64	65	4.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	100	NA	CT chest/abdomen/pelvis	NA	NA	NA	NA	4/4/18	NA	23742	NSCLC	7.9	23712	23665	1	FALSE	NA	FALSE	NA	23742	0.0000	IMPACT468	70	Adenocarcinoma	No	MSKCC	Pembrolizumab	2	95	Yes	NA	FALSE	NA	NA	PD1 alone	2018/04	NA	0	Do not report	999292	NA	LUAD	2.5	NA	20	YES	lung	23726	2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	428	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	Included	FALSE	NA	0	10	SOC	Yes	2018, Wk. 14	NA
lung_msk_mind_2020	P-0025016	P-0025016-T01-IM6	78	79	3.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	70	NA	CT chest	94.1	19.3	93.3	NA	11/30/17	NA	29317	NSCLC	3.1	28952	28758	1	FALSE	NA	FALSE	NA	29317	0.1231	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	70	No	Pleura	FALSE	NA	NA	PD1 alone	2017/11	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	762516	21	NSCLC	18.4	NA	37.5	YES	pleura	28909	5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	440	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	19.3	40	SOC	Yes	2017, Wk. 48	NA
lung_msk_mind_2020	P-0025018	P-0025018-T01-IM6	78	79	3.1	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	62.5	5.3	45.6	Cytolyt	12/1/17	NA	28694	NSCLC	3.7	28668	28647	1	TRUE	AMP (driver), EGFR-LANCL2 fusion	FALSE	NA	28694	0.0010	IMPACT468	80	Squamous	Yes	MSKCC	Atezolizumab	2	0	No	Lymph Node	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	769138	5	LUSC	1.5	NA	35	YES	lymph node	28694	1.5	1:PROGRESS	Lung	NA	FALSE	G798D	FALSE	NA	Tumor	1	970	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	5.3	10	SOC	Yes	2017, Wk. 48	NA
lung_msk_mind_2020	P-0025245	P-0025245-T01-IM6	43	43	4.3	FALSE	NA	NO	TRUE	Q766Sfs*67 (driver)	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	75	NA	CT chest/abdomen/pelvis	98.4	51.8	99.6	NA	12/7/17	NA	16105	NSCLC	2.8	16008	15917	0	FALSE	NA	TRUE	Y772_A775dup (driver)	16105	0.0954	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	3	80	No	NA	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	8.96	Indeterminate	889768	59	LUAD	6.2	NA	18	YES	lung	16025	3.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	S340F	Tumor	1	572	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	51.8	20	SOC	Yes	2017, Wk. 49	NA
lung_msk_mind_2020	P-0025354	P-0025354-T01-IM6	60	60	4.2	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	87.1	10.5	77	NA	12/9/17	Durable clinical benefit	NA	NSCLC	1.4	22076	21961	2	FALSE	NA	FALSE	NA	22366	0.1563	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	888320	12	LUAD	NA	NA	92	YES	lung	22300	11.1	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	672	Primary	Female	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Included	TRUE	P281Rfs*6 (driver), Y166* (driver)	10.5	40	SOC	No	2017, Wk. 49	NA
lung_msk_mind_2020	P-0025465	P-0025465-T01-IM6	67	68	4	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	70	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	12/22/17	NA	NA	NSCLC	5.4	25134	24763	1	FALSE	NA	FALSE	NA	25386	0.0025	IMPACT468	60	Squamous	Yes	MSKCC	Pembrolizumab	1	80	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	892695	2	LUAD	NA	NA	20	YES	lymph node	25150	12.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	762	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less). Negative MSIsensor, copy number and structural variant results should be interpreted with caution.  Additional mutations may not be detected due to low tumor content. Note: This sample has been nominate	Included	FALSE	NA	1.8	10	SOC	No	2017, Wk. 51	NA
lung_msk_mind_2020	P-0025598	P-0025598-T01-IM6	58	59	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest	91	13.2	85.8	NA	12/21/17	NA	21498	NSCLC	2.3	21454	21321	0	FALSE	NA	FALSE	NA	21498	0.1604	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	60	No	NA	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0.41	Stable	897420	15	LUAD	5.8	NA	15	YES	lung	21396	2.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	874	Primary	Female	Former smoker	Matched	NA	Included	FALSE	D237H	13.2	40	SOC	Yes	2017, Wk. 51	NA
lung_msk_mind_2020	P-0025657	P-0025657-T02-IM6	68	69	3.1	FALSE	NA	YES	FALSE	NA	SD	FALSE	NA	Lung Squamous Cell Carcinoma	Lung Squamous Cell Carcinoma	90	NA	CT chest/abdomen/pelvis	78.5	7.9	64.1	NA	9/27/18	No durable clinical benefit	NA	NSCLC	3.3	25142	25093	1	TRUE	AMP (driver)	FALSE	NA	25446	0.1319	IMPACT468	95	NOS	No	MSKCC	Pembrolizumab	2	90	No	Muscle	TRUE	AMP (driver), X963_splice (driver), MET-intragenic - Archer	NA	PD1 alone	2018/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	NA	8	LUSC	NA	NA	0	NO	lymph node	25156	2.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	532	Metastasis	Female	Never smoker	Matched	NA	Included	FALSE	NA	7.9	30	SOC	No	2018, Wk. 39	NA
lung_msk_mind_2020	P-0025777	P-0025777-T01-IM6	49	49	4.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	12/30/17	NA	18198	NSCLC	2.4	18136	18136	1	FALSE	NA	FALSE	NA	18198	0.2484	IMPACT468	70	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	0	No	Brain	FALSE	NA	NA	PD1 alone	2017/12	MICROSATELLITE STABLE (MSS). See MSI note below.	0.47	Stable	903204	3	LUAD	2	NA	unk	YES	bone	18186	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	648	Metastasis	Female	Former smoker	Matched	NA	Included	TRUE	P221Lfs*66 (driver)	2.6	70	SOC	Yes	2017, Wk. 52	NA
lung_msk_mind_2020	P-0025917	P-0025917-T02-IM6	62	63	3.3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	96.2	30.7	97.8	NA	1/24/18	NA	22908	NSCLC	13.8	22816	22773	2	FALSE	NA	FALSE	NA	22908	0.1477	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	C584Wfs*10	NA	PD1 alone	2018/01	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	5.06	Indeterminate	916722	35	LUAD	4.4	NA	37	YES	lung	22825	1.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	P826L	Tumor	1	262	Primary	Female	Former smoker	Matched	NA	Included	FALSE	STK11-intragenic	30.7	40	SOC	Yes	2018, Wk. 04	NA
lung_msk_mind_2020	P-0025956	P-0025956-T01-IM6	71	72	3.7	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	63.5	5.3	46.4	NA	1/13/18	NA	26048	NSCLC	1.3	25993	25925	0	FALSE	NA	FALSE	NA	26048	0.0785	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2018/01	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	573386	6	LUAD	4	NA	25	YES	lung	26003	2.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	604	Primary	Female	Former smoker	Matched	NA	Included	TRUE	P281Rfs*6 (driver)	5.3	20	SOC	Yes	2018, Wk. 02	NA
lung_msk_mind_2020	P-0026121	P-0026121-T01-IM6	70	71	2.7	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Pleomorphic Carcinoma of the Lung	100	NA	CT chest/abdomen/pelvis	44.1	3.5	30.4	NA	7/14/18	NA	26155	NSCLC	4.9	26050	25903	1	FALSE	NA	FALSE	NA	26155	0.1062	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	No	Pleura	TRUE	AMP (driver)	NA	PD1 alone	2018/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	908764	4	LUPC	8.3	NA	50	YES	pleura	26071	5.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	439	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	3.5	30	SOC	Yes	2018, Wk. 28	NA
lung_msk_mind_2020	P-0026289	P-0026289-T01-IM6	58	58	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	1/23/18	NA	NA	NSCLC	1.7	21512	21173	1	FALSE	NA	FALSE	R970L	21804	0.0088	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	50	No	NA	FALSE	NA	NA	PD1 alone	2018/01	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	914999	12	LUAD	NA	NA	unk	YES	lung	21677	16.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	537	Primary	Female	Former smoker	Matched	Note: Multiple deletion events in GNAS involving exons 1-13 in the tumor sample may suggest the presence of somatically acquired processed pseudogenes.	Included	FALSE	NA	10.5	20	SOC	No	2018, Wk. 04	NA
lung_msk_mind_2020	P-0026521	P-0026521-T01-IM6	81	81	4.1	FALSE	NA	NO	TRUE	F2141Sfs*59 (driver)	POD	FALSE	NA	Large Cell Lung Carcinoma	Large Cell Lung Carcinoma	0	NA	CT chest/abdomen/pelvis	95	23.7	96.1	NA	1/30/18	NA	NA	NSCLC	1.5	29654	29598	1	FALSE	NA	FALSE	NA	29955	0.5130	IMPACT468	NA	NOS	Yes	MSKCC	Nivolumab	2	NA	NA	Brain	FALSE	NA	NA	PD1 alone	2018/01	MICROSATELLITE STABLE (MSS). See MSI note below.	1.13	Stable	928666	27	LCLC	NA	NA	37.5	YES	brain	29654	1.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	734	Metastasis	Male	Former smoker	Matched	NA	Excluded	FALSE	NA	23.7	80	SOC	No	2018, Wk. 05	NA
lung_msk_mind_2020	P-0026552	P-0026552-T02-IM6	66	69	3.4	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	0	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	7/17/18	NA	NA	NSCLC	2.3	24654	24416	1	FALSE	NA	FALSE	NA	25152	0.0661	IMPACT468	95	Large cell neuroendocrine	No	MSKCC	Nivolumab	2	5	No	Axilla	FALSE	NA	NA	PD1 alone	2018/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1102389	6	LUNE	NA	NA	33	YES	lymph node	24671	8.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	735	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	5.3	30	SOC	No	2018, Wk. 29	NA
lung_msk_mind_2020	P-0026574	P-0026574-T02-IM6	76	77	3.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	30	NA	CT chest/abdomen/pelvis	92.3	14.9	89.1	NA	3/20/18	NA	NA	NSCLC	2.7	28037	27789	1	FALSE	NA	FALSE	NA	28072	0.0933	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	30	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	974581	17	LUSC	NA	NA	50	YES	lung	28071	9.3	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	435	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	14.9	30	SOC	No	2018, Wk. 12	NA
lung_msk_mind_2020	P-0026958	P-0026958-T01-IM6	73	74	3.2	FALSE	NA	NO	FALSE	NA	POD/clinical	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	80	NA	CT chest/abdomen/pelvis	85.9	9.7	74.8	NA	2/9/18	NA	NA	NSCLC	1.9	26921	26921	3	FALSE	NA	FALSE	NA	26940	0.0565	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	80	No	NA	FALSE	NA	NA	PD1 alone	2018/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	944455	11	NSCLC	NA	NA	33.75	YES	lung	26940	0.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	725	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.	Included	FALSE	NA	9.7	20	SOC	No	2018, Wk. 06	NA
lung_msk_mind_2020	P-0027088	P-0027088-T01-IM6	45	46	3.2	FALSE	NA	YES	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	95	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	2/17/18	NA	16719	NSCLC	4.9	16711	16690	2	FALSE	NA	FALSE	NA	16719	0.4015	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	No	NA	FALSE	NA	NA	PD1 alone	2018/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	946691	2	LUAD	1	NA	8.5	YES	pleura	16719	1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	717	Primary	Male	Former smoker	Matched	Note: This sample has been nominated for further analysis using the Archer targeted RNAseq assay as an apparent driver-negative cancer. Assay will be performed if additional material is available and results will be reported under a separate accession num	Included	FALSE	NA	1.8	30	SOC	Yes	2018, Wk. 07	NA
lung_msk_mind_2020	P-0027133	P-0027133-T01-IM6	58	59	4.1	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	60	NA	CT chest	89.7	12.3	82.3	NA	2/17/18	NA	21495	NSCLC	2.3	21468	21436	1	FALSE	NA	FALSE	NA	21495	0.1336	IMPACT468	70	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	60	Yes	NA	FALSE	NA	NA	PD1 alone	2018/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	931191	14	LUAD	1.9	NA	76.5	YES	lung	21495	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	975	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	12.3	20	SOC	Yes	2018, Wk. 07	NA
lung_msk_mind_2020	P-0027259	P-0027259-T02-IM6	69	70	3	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	5	NA	CT chest/abdomen/pelvis	92.3	14.9	89.1	NA	6/8/18	NA	25457	NSCLC	6	25435	25400	2	FALSE	NA	FALSE	NA	25457	0.0628	IMPACT468	95	Squamous	Yes	MSKCC	Nivolumab	2	1	No	Soft Tissue	FALSE	NA	NA	PD1 alone	2018/06	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	1061488	17	LUSC	1.9	NA	79.5	YES	soft tissue (gluteus)	25450	1.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	649	Metastasis	Male	Former smoker	Matched	Note: This tumor sample is clonally related to the sample tested in M18-3034.. Note: Copy number profile is suggestive of broad copy number gain on Chromosome 20q11-13.	Included	FALSE	NA	14.9	30	SOC	Yes	2018, Wk. 23	NA
lung_msk_mind_2020	P-0027343	P-0027343-T01-IM6	93	>90	3.3	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	87.1	10.5	77	NA	2/25/18	NA	34153	NSCLC	2.1	34149	34149	2	FALSE	NA	FALSE	NA	34153	0.1779	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	80	No	Bone	FALSE	NA	NA	PD1 alone	2018/02	MICROSATELLITE STABLE (MSS). See MSI note below.	0.3	Stable	909664	10	LUAD	0.1	NA	unk	YES	soft tissue (humerus)	34153	0.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	793	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	10.5	30	SOC	Yes	2018, Wk. 08	NA
lung_msk_mind_2020	P-0027455	P-0027455-T01-IM6	72	73	3.3	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	50	NA	CT chest	NA	NA	NA	NA	3/2/18	Durable clinical benefit	NA	NSCLC	3.8	27055	26612	1	FALSE	NA	FALSE	NA	27200	0.0029	IMPACT468	NA	Squamous	Yes	MSKCC	Pembrolizumab	1	NA	NA	NA	FALSE	NA	NA	PD1 alone	2018/03	NA	0	Do not report	963315	NA	NSCLC	NA	NA	60	YES	lung	27073	15.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	622	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	Excluded	FALSE	NA	0	10	SOC	No	2018, Wk. 09	NA
lung_msk_mind_2020	P-0027576	P-0027576-T01-IM6	65	65	3.7	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	3/9/18	NA	23889	NSCLC	3.9	23799	23799	2	FALSE	NA	FALSE	NA	23889	0.0105	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Chest Wall	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	940732	5	LUAD	3	NA	35	YES	chest wall	23822	0.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	516	Metastasis	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	4.4	10	SOC	Yes	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027664	P-0027664-T01-IM6	68	69	3.6	FALSE	NA	YES	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	54.1	4.4	38.5	NA	3/7/18	NA	NA	NSCLC	2	25298	25135	1	TRUE	AMP (driver)	FALSE	NA	25361	0.2163	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	948171	5	LUAD	NA	NA	50	YES	lung	25172	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	870	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	4.4	30	SOC	No	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027673	P-0027673-T01-IM6	71	71	3.2	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	91.4	14	86.9	NA	3/8/18	NA	NA	NSCLC	2.9	26527	26029	2	FALSE	NA	FALSE	NA	26542	0.7096	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	1	0	No	Lymph node	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.77	Stable	922319	16	LUAD	NA	NA	72	YES	lymph node	26439	13.5	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	809	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	14	50	SOC	No	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027713	P-0027713-T01-IM6	73	73	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	3/9/18	NA	NA	NSCLC	2.5	26829	26801	1	FALSE	NA	FALSE	NA	27294	0.0697	IMPACT468	95	Squamous	Yes	MSKCC	Nivolumab	3	0	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	968721	3	LUSC	NA	NA	30	YES	lung	26836	1.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	1084	Primary	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q.	Included	FALSE	NA	2.6	30	SOC	No	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027726	P-0027726-T01-IM6	66	67	3.7	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	30	NA	CT chest/abdomen/pelvis	94.3	20.2	93.7	NA	3/23/18	Durable clinical benefit	NA	NSCLC	2.4	24539	24266	1	FALSE	NA	FALSE	NA	24749	0.0297	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	30	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.1	Stable	988516	23	LUAD	NA	NA	43	YES	lung	24560	9.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	724	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	20.2	30	SOC	No	2018, Wk. 12	NA
lung_msk_mind_2020	P-0027733	P-0027733-T01-IM6	86	88	3.5	FALSE	NA	NO	FALSE	NA	CR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	0	0	0	NA	3/11/18	NA	32066	NSCLC	2.3	31778	31590	1	FALSE	NA	FALSE	NA	32066	0.0003	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	80	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	533441	NA	LUAD	15.6	NA	60	YES	lung	32066	15.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	492	Primary	Male	Former smoker	Matched	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	Included	FALSE	NA	0	10	SOC	Yes	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027742	P-0027742-T01-IM6	62	62	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	25.2	1.8	16.1	NA	3/9/18	NA	23001	NSCLC	1.5	22735	22693	1	FALSE	NA	FALSE	NA	23001	0.0479	IMPACT468	NA	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	NA	NA	Spine	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.3	Stable	972839	2	LUAD	10.1	NA	unk	YES	soft tissue (spine)	22739	1.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	625	Metastasis	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Excluded	FALSE	NA	1.8	10	SOC	Yes	2018, Wk. 10	NA
lung_msk_mind_2020	P-0027855	P-0027855-T01-IM6	81	81	4.1	FALSE	NA	NO	FALSE	NA	POD/death	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	2	NA	CT chest/abdomen/pelvis	76.6	7	60.3	NA	3/13/18	NA	29734	NSCLC	3.5	29710	29647	1	FALSE	NA	TRUE	AMP (driver)	29734	0.3165	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	5	No	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	964559	8	LUAD	2.9	NA	4.5	YES	lung	29734	2.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	773	Primary	Male	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 5p (including TERT), and 6p21.2-25.	Included	TRUE	P281Rfs*6 (driver)	7	30	SOC	Yes	2018, Wk. 11	NA
lung_msk_mind_2020	P-0028173	P-0028173-T01-IM6	71	71	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	54.1	4.4	38.5	NA	3/22/18	NA	26086	NSCLC	2.4	26017	25981	1	FALSE	NA	FALSE	NA	26086	0.2116	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Soft Tissue	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	984337	5	LUAD	3.4	NA	40	YES	soft tissue (T9)	26040	1.9	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	438	Metastasis	Female	Former smoker	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q. Note: Copy number profile is suggestive of broad copy number loss on Chromosome 1p, 3p, 9, 18q and 19p (including STK11 and KEAP1).	Included	TRUE	Q220Pfs*45 (driver)	4.4	50	SOC	Yes	2018, Wk. 12	NA
lung_msk_mind_2020	P-0028204	P-0028204-T01-IM6	77	78	3.9	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	5	NA	CT chest/abdomen/pelvis	63.5	5.3	46.4	NA	3/23/18	NA	NA	NSCLC	1.8	28438	28438	1	FALSE	NA	FALSE	NA	28957	0.0160	IMPACT468	NA	Squamous	Yes	MSKCC	Pembrolizumab	2	80	NA	NA	TRUE	X963_splice (driver)	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	986129	6	LUSC	NA	NA	90	YES	lung	28477	1.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	778	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Excluded	FALSE	NA	5.3	30	SOC	No	2018, Wk. 12	NA
lung_msk_mind_2020	P-0028239	P-0028239-T01-IM6	80	80	3.8	FALSE	NA	YES	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	3/23/18	Durable clinical benefit	29475	NSCLC	5.2	29376	29277	0	FALSE	NA	FALSE	NA	29475	0.1721	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	Soft Tissue	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.1	Stable	983501	2	LUAD	6.5	NA	75	YES	soft tissue (C2)	29475	6.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	487	Metastasis	Male	Former smoker	Matched	Note: Copy number profile from IMPACT assay and allele specific copy number analysis by FACETS suggest loss of heterozygosity of BAP1. The results by FACETS are for investigational use. Confirmation of copy number changes by alternate methods is suggested	Included	FALSE	NA	1.8	60	SOC	Yes	2018, Wk. 12	NA
lung_msk_mind_2020	P-0028320	P-0028320-T01-IM6	60	70	3.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	20	NA	CT chest/abdomen	92.8	16.7	90.4	NA	3/30/18	NA	25698	NSCLC	1.9	25657	25657	1	FALSE	NA	FALSE	NA	25698	0.3516	IMPACT468	60	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	1	Yes	NA	FALSE	NA	NA	PD1 alone	2018/03	MICROSATELLITE STABLE (MSS). See MSI note below.	1.34	Stable	988637	18	LUAD	1.3	NA	30	YES	lung	25693	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	848	Primary	Female	Former smoker	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Included	FALSE	NA	16.7	50	SOC	Yes	2018, Wk. 13	NA
lung_msk_mind_2020	P-0028473	P-0028473-T01-IM6	70	71	4.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	10	NA	CT chest	96.5	31.6	97.7	NA	4/2/18	NA	NA	NSCLC	3.4	26338	25803	1	FALSE	NA	FALSE	NA	26359	0.4741	IMPACT468	50	NOS	Yes	MSKCC	Ipilimumab+Nivolumab	1	10	Yes	Adrenal Gland	FALSE	NA	NA	PD1+CTLA4	2018/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	981110	36	NSCLCPD	NA	NA	45	YES	adrenal	26333	17.4	0:CENSORED	Lung	NA	FALSE	NA	FALSE	L545F	Tumor	1	533	Metastasis	Male	Former smoker	Matched	Note: Allele specific copy number analysis by FACETS suggests loss of heterozygosity in SMARCA4. FACETS results are for investigational use only.	Included	FALSE	NA	31.6	40	SOC	No	2018, Wk. 14	NA
lung_msk_mind_2020	P-0028712	P-0028712-T01-IM6	67	68	3.7	FALSE	NA	YES	TRUE	K1862* (driver)	POD/brain	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	94.3	20.2	93.7	NA	4/6/18	NA	25128	NSCLC	1.5	24726	24679	1	FALSE	NA	FALSE	NA	25128	0.5320	IMPACT468	80	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	10	Yes	Brain	FALSE	NA	NA	PD1 alone	2018/04	MICROSATELLITE STABLE (MSS). See MSI note below.	1.58	Stable	1000381	23	LUAD	14.8	NA	80	YES	brain	24836	5.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	338	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	20.2	60	SOC	Yes	2018, Wk. 14	NA
lung_msk_mind_2020	P-0028723	P-0028723-T01-IM6	65	65	3.4	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	100	NA	CT chest	89	11.4	81.7	Formalin	4/6/18	NA	NA	NSCLC	2.4	24267	23742	1	FALSE	NA	FALSE	NA	24267	0.1098	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	No	Pleural Fluid	FALSE	NA	NA	PD1 alone	2018/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	1002095	13	LUAD	NA	NA	40.5	YES	pleural fluid	24197	14.9	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	570	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	11.4	50	SOC	No	2018, Wk. 14	NA
lung_msk_mind_2020	P-0028930	P-0028930-T01-IM6	70	70	3.9	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest	79.1	7.9	63.8	Formalin	4/19/18	NA	25931	NSCLC	2.7	25791	25728	1	FALSE	NA	FALSE	NA	25931	0.0309	IMPACT468	50	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	5	Yes	Lymph Node	FALSE	NA	NA	PD1 alone	2018/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1011753	9	LUAD	6.7	NA	25	YES	lymph node	25859	4.3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	462	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile from IMPACT assay and allele specific copy number analysis by FACETS suggest loss of heterozygosity in Chromosome arm 19p13, including SMARCA4.	Included	FALSE	NA	7.9	40	SOC	Yes	2018, Wk. 16	NA
lung_msk_mind_2020	P-0029148	P-0029148-T01-IM6	68	68	3.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest/abdomen/pelvis	92.8	16.7	90.4	NA	5/1/18	NA	NA	NSCLC	1.3	25364	24852	1	FALSE	NA	FALSE	NA	25384	0.0064	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	90	No	NA	FALSE	NA	NA	PD1 alone	2018/05	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	973184	19	LUAD	NA	NA	10	YES	lung	25147	9.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	647	Primary	Male	Former smoker	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation may not be detected due to low tumor content.	Included	FALSE	NA	16.7	20	SOC	No	2018, Wk. 18	NA
lung_msk_mind_2020	P-0029298	P-0029298-T01-IM6	62	63	4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	10	NA	CT chest/abdomen/pelvis	92.5	15.8	89.7	NA	4/27/18	NA	23074	NSCLC	2.9	22958	22893	1	FALSE	NA	FALSE	NA	23074	0.9338	IMPACT468	NA	Squamous	Yes	MSKCC	Pembrolizumab	3	NA	NA	Liver	FALSE	NA	NA	PD1 alone	2018/04	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.11	Indeterminate	1019424	18	LUSC	5.9	NA	22.5	YES	liver	22970	2.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	673	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	Excluded	FALSE	NA	15.8	70	SOC	Yes	2018, Wk. 17	NA
lung_msk_mind_2020	P-0029465	P-0029465-T01-IM6	56	57	3.9	FALSE	NA	NO	FALSE	K1124M	PR	FALSE	P328S	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	1	NA	CT chest	87.1	10.5	77	NA	5/7/18	NA	NA	NSCLC	0.8	21094	20630	1	FALSE	NA	FALSE	NA	21108	0.4164	IMPACT468	NA	Squamous	No	MSKCC	Nivolumab	1	NA	NA	Lymph Node	FALSE	NA	NA	PD1 alone	2018/05	MICROSATELLITE STABLE (MSS). See MSI note below.	1.18	Stable	1024805	12	LUSC	NA	NA	20	YES	lung	21093	15.2	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	810	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Excluded	FALSE	NA	10.5	50	SOC	No	2018, Wk. 19	NA
lung_msk_mind_2020	P-0029593	P-0029593-T01-IM6	75	76	3.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	75	NA	CT chest/abdomen/pelvis	87.1	10.5	77	SSL	5/6/18	NA	NA	NSCLC	0.9	28079	27589	1	FALSE	NA	FALSE	NA	28105	0.4443	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	80	No	Pleural Fliud	FALSE	NA	NA	PD1 alone	2018/05	MICROSATELLITE STABLE (MSS). See MSI note below.	0.4	Stable	1032740	12	LUAD	NA	NA	60	YES	pleural fluid	27855	8.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	655	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	10.5	50	SOC	No	2018, Wk. 18	NA
lung_msk_mind_2020	P-0029975	P-0029975-T01-IM6	65	67	4.2	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Lung Squamous Cell Carcinoma	Lung Squamous Cell Carcinoma	80	NA	CT chest/abdomen/pelvis	61.9	5.3	45.8	NA	5/19/18	NA	NA	NSCLC	1	24390	23928	0	FALSE	NA	FALSE	NA	24432	0.3543	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	1	80	No	Liver	FALSE	NA	NA	PD1 alone	2018/05	MICROSATELLITE STABLE (MSS). See MSI note below.	1.52	Stable	1044108	5	LUSC	NA	NA	52	YES	liver	24275	11.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	767	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	Included	FALSE	NA	5.3	70	SOC	No	2018, Wk. 20	NA
lung_msk_mind_2020	P-0030125	P-0030125-T01-IM6	66	67	3.8	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	13.1	0.9	7.8	NA	5/26/18	Durable clinical benefit	24433	NSCLC	1.7	24289	24107	1	FALSE	NA	FALSE	NA	24433	0.0003	IMPACT468	90	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2018/05	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	1044051	1	LUAD	10.7	NA	24.5	YES	lung	24302	6.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	322	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	0.9	10	SOC	Yes	2018, Wk. 21	NA
lung_msk_mind_2020	P-0030323	P-0030323-T01-IM6	61	63	4.3	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Pleomorphic Carcinoma of the Lung	0	NA	CT chest	92.3	14.9	89.1	NA	6/2/18	NA	NA	NSCLC	3	22882	22427	0	FALSE	NA	FALSE	NA	22973	0.0268	IMPACT468	95	Pleomorphic	Yes	MSKCC	Pembrolizumab	1	10	No	Adrenal	FALSE	NA	NA	PD1 alone	2018/06	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1002031	17	LUPC	NA	NA	40	YES	adrenal	22716	9.5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	770	Metastasis	Male	Former smoker	Matched	NA	Included	FALSE	NA	14.9	40	SOC	No	2018, Wk. 22	NA
lung_msk_mind_2020	P-0030654	P-0030654-T01-IM6	75	76	3.6	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	80	NA	CT chest/abdomen/pelvis	91	13.2	85.8	NA	6/18/18	NA	27615	NSCLC	2.2	27482	27461	1	FALSE	L369F	FALSE	NA	27615	0.2123	IMPACT468	95	Squamous	Yes	MSKCC	Pembrolizumab	2	80	No	NA	FALSE	NA	NA	PD1 alone	2018/06	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1063249	15	LUSC	5.1	NA	60	YES	lung	27496	1.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	P2183S	Tumor	1	775	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	13.2	30	SOC	Yes	2018, Wk. 25	NA
lung_msk_mind_2020	P-0031112	P-0031112-T02-IM6	64	66	3.3	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	70	NA	CT chest/abdomen	76.6	7	60.3	NA	8/8/18	NA	24085	NSCLC	1.6	23710	23430	1	FALSE	NA	FALSE	NA	24085	0.0006	IMPACT468	95	Squamous	No	MSKCC	Pembrolizumab	1	70	No	kidney	FALSE	NA	NA	PD1 alone	2018/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1134880	8	LUSC	21.5	NA	48	YES	lung	23603	5.7	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	506	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	7	10	SOC	Yes	2018, Wk. 32	NA
lung_msk_mind_2020	P-0031665	P-0031665-T01-IM6	71	72	3.2	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	79.1	7.9	63.8	NA	7/14/18	No durable clinical benefit	26134	NSCLC	2.9	25965	25951	1	FALSE	D416Y	FALSE	NA	26134	0.3237	IMPACT468	70	Squamous	Yes	MSKCC	Nivolumab	3	0	No	Chest Wall	FALSE	NA	NA	PD1 alone	2018/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	1096950	9	LUSC	6	NA	67.5	YES	chest wall	26042	3	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	718	Metastasis	Male	Former smoker	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Included	FALSE	NA	7.9	40	SOC	Yes	2018, Wk. 28	NA
lung_msk_mind_2020	P-0031727	P-0031727-T01-IM6	84	85	4.3	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	100	NA	CT chest/abdomen/pelvis	44.1	3.5	30.4	NA	7/17/18	NA	NA	NSCLC	2	31258	30672	1	FALSE	NA	FALSE	NA	31279	0.0009	IMPACT468	80	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	Yes	NA	TRUE	H1094Y (driver)	NA	PD1 alone	2018/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	922342	4	LUAD	NA	NA	34	YES	lung	31273	19.7	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	568	Primary	Female	Former smoker	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	3.5	10	SOC	No	2018, Wk. 29	NA
lung_msk_mind_2020	P-0032126	P-0032126-T01-IM6	77	80	3.5	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	50	NA	CT chest	76.6	7	60.3	NA	7/31/18	NA	28732	NSCLC	13.4	28585	28410	1	FALSE	R98L	FALSE	NA	28732	0.0072	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	2	50	No	NA	FALSE	NA	NA	PD1 alone	2018/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1118037	8	LUAD	10.6	NA	50	YES	lung	28671	8.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	771	Primary	Female	Former smoker	Matched	NA	Included	TRUE	F231Sfs*56 (driver)	7	10	SOC	Yes	2018, Wk. 31	NA
lung_msk_mind_2020	P-0032182	P-0032182-T01-IM6	62	64	4.1	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer	90	NA	CT chest	44.1	3.5	30.4	NA	8/1/18	No durable clinical benefit	NA	NSCLC	6.3	23082	22926	1	FALSE	NA	FALSE	NA	23385	0.0932	IMPACT468	95	NOS	Yes	MSKCC	Pembrolizumab	1	95	No	NA	FALSE	NA	NA	PD1 alone	2018/08	MICROSATELLITE STABLE (MSS). See MSI note below.	0.8	Stable	1119410	4	NSCLCPD	NA	NA	50	YES	lung	23077	5	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	570	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	3.5	60	SOC	No	2018, Wk. 31	NA
lung_msk_mind_2020	P-0032455	P-0032455-T01-IM6	64	65	3.9	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	91	13.2	85.8	Formalin	8/11/18	NA	NA	NSCLC	2	23964	23488	2	FALSE	NA	FALSE	NA	23989	0.4903	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	90	No	NA	TRUE	AMP (driver)	NA	PD1 alone	2018/08	MICROSATELLITE STABLE (MSS). See MSI note below.	2.05	Stable	1039320	15	LUAD	NA	NA	36	YES	lymph node	23940	14.8	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	648	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	13.2	60	SOC	No	2018, Wk. 32	NA
lung_msk_mind_2020	P-0033239	P-0033239-T01-IM6	59	61	3.8	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	10	NA	CT chest/abdomen/pelvis	25.2	1.8	16.1	NA	9/12/18	No durable clinical benefit	NA	NSCLC	1.5	21932	21823	1	FALSE	NA	FALSE	NA	22264	0.1033	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	10	No	Abdomen	FALSE	NA	NA	PD1 alone	2018/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0.43	Stable	NA	2	LUAD	NA	NA	0	NO	peritoneum	21950	4.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	363	Metastasis	Female	Former smoker	Matched	NA	Included	FALSE	NA	1.8	30	SOC	No	2018, Wk. 37	NA
lung_msk_mind_2020	P-0033892	P-0033892-T01-IM6	64	66	3.5	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	87.1	10.5	77	SSL	10/9/18	NA	23751	NSCLC	1.3	23686	23590	1	TRUE	AMP (driver)	FALSE	NA	23751	0.3628	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	Pleural Fluid	FALSE	NA	NA	PD1 alone	2018/10	MICROSATELLITE STABLE (MSS). See MSI note below.	0.66	Stable	NA	12	LUAD	5.3	NA	24	NO	pleural fluid	23634	1.4	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	635	Metastasis	Female	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	10.5	40	SOC	Yes	2018, Wk. 41	NA
lung_msk_mind_2020	P-0033978	P-0033978-T01-IM6	51	53	3.9	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	80	NA	CT chest/abdomen/pelvis	37.9	2.6	25.7	NA	9/29/18	Durable clinical benefit	NA	NSCLC	1.9	18842	18799	0	FALSE	NA	FALSE	NA	19395	0.0097	IMPACT468	95	Adenocarcinoma	No	MSKCC	Pembrolizumab	2	90	No	NA	FALSE	NA	NA	PD1 alone	2018/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	3	LUAD	NA	NA	25	NO	lung	18987	6.2	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	456	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.	Included	FALSE	NA	2.6	10	SOC	No	2018, Wk. 39	NA
lung_msk_mind_2020	P-0033979	P-0033979-T01-IM6	71	73	3	FALSE	NA	YES	FALSE	NA	PR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	14.3	0.9	8.9	NA	9/29/18	NA	NA	NSCLC	5.1	26227	26199	1	FALSE	NA	FALSE	NA	26552	0	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Atezolizumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2018/09	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	1	LUAD	NA	NA	62.5	NO	lung	26339	4.6	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	495	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	0.9	20	SOC	No	2018, Wk. 39	NA
lung_msk_mind_2020	P-0034908	P-0034908-T01-IM6	76	77	3.8	FALSE	NA	NO	FALSE	Y803C	CR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	50	NA	CT chest	73.7	6.1	56.8	NA	11/8/18	NA	NA	NSCLC	1.8	28089	27762	2	FALSE	NA	FALSE	NA	28101	0.6205	IMPACT468	80	Squamous	No	MSKCC	Pembrolizumab	1	60	No	Lymph Node	FALSE	NA	NA	PD1 alone	2018/11	MICROSATELLITE STABLE (MSS). See MSI note below.	2.1	Stable	NA	7	LUSC	NA	NA	36	NO	lung	28087	10.7	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	707	Metastasis	Male	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	Included	TRUE	E199* (driver)	6.1	30	SOC	No	2018, Wk. 45	NA
lung_msk_mind_2020	P-0035638	P-0035638-T01-IM6	72	73	3.4	FALSE	NA	NO	FALSE	NA	POD	FALSE	NA	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	0	NA	CT chest/abdomen/pelvis	91	13.2	85.8	NA	11/27/18	NA	26634	NSCLC	4.9	26476	26392	1	FALSE	NA	FALSE	P627S	26634	0.7310	IMPACT468	95	Squamous	Yes	MSKCC	Nivolumab	1	0	No	NA	FALSE	NA	NA	PD1 alone	2018/11	MICROSATELLITE STABLE (MSS). See MSI note below.	2.41	Stable	NA	15	LUSC	8	NA	0	NO	lung	26485	3.1	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	445	Primary	Male	Never smoker	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Included	FALSE	NA	13.2	80	SOC	Yes	2018, Wk. 48	NA
lung_msk_mind_2020	P-0039832	P-0039832-T01-IM6	75	76	3.4	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	90	NA	CT chest/abdomen/pelvis	89.5	12.3	82.1	SSL	3/26/19	NA	NA	NSCLC	1.6	27762	27403	1	FALSE	NA	FALSE	NA	27787	0.1493	IMPACT468	50	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	1	95	Yes	NA	FALSE	NA	NA	PD1 alone	2019/03	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	1167331	14	LUAD	NA	NA	22.5	YES	pleural fluid	27739	11	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	545	Primary	Female	Former smoker	Matched	NA	Included	FALSE	NA	12.3	30	SOC	No	2019, Wk. 13	NA
lung_msk_mind_2020	P-0040848	P-0040848-T01-IM6	70	71	3.5	FALSE	NA	NO	FALSE	NA	SD	FALSE	NA	Lung Squamous Cell Carcinoma	Lung Squamous Cell Carcinoma	90	NA	CT chest/abdomen/pelvis	61.9	5.3	45.8	SSL	4/24/19	Durable clinical benefit	NA	NSCLC	1.7	26018	25675	1	FALSE	NA	FALSE	NA	26127	0.3339	IMPACT468	95	Squamous	Yes	Other Institute	Pembrolizumab	2	80	No	NA	FALSE	NA	NA	PD1 alone	2019/04	MICROSATELLITE STABLE (MSS). See MSI note below.	0.52	Stable	1578306	6	LUSC	NA	NA	55	YES	peritoneum	26033	11.8	1:PROGRESS	Lung	NA	FALSE	NA	FALSE	C2252F	Tumor	1	486	Primary	Female	Current smoker (within 6 months of diagnosis)	Matched	Note: Copy number profile is suggestive of multiple chromosome level losses and gains.	Included	FALSE	NA	5.3	50	SOC	No	2019, Wk. 17	NA
lung_msk_mind_2020	P-0044186	P-0044186-T01-IM6	65	68	4.1	FALSE	NA	NO	FALSE	NA	PR	FALSE	NA	Lung Adenocarcinoma	Lung Adenocarcinoma	1	NA	CT chest	89.3	12.3	82.3	NA	7/20/19	NA	NA	NSCLC	2.4	24000	23958	1	FALSE	NA	FALSE	NA	24570	0.0866	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Pembrolizumab	2	5	No	NA	FALSE	NA	NA	PD1 alone	2019/07	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	549270	14	LUAD	NA	NA	38	YES	lung	24549	19.4	0:CENSORED	Lung	NA	FALSE	NA	FALSE	NA	Tumor	1	792	Primary	Male	Current smoker (within 6 months of diagnosis)	Matched	NA	Included	FALSE	NA	12.3	40	SOC	No	2019, Wk. 29	NA
lung_msk_mind_2020	P-0045298	P-0045298-T01-IM6	74	77	3.6	FALSE	NA	NO	TRUE	D1850Gfs*4 (driver)	PR	FALSE	L185P	Lung Adenocarcinoma	Lung Adenocarcinoma	0	NA	CT chest/abdomen/pelvis	96.1	29.8	97.7	NA	8/22/19	NA	NA	NSCLC	1.9	27680	27233	1	FALSE	NA	FALSE	NA	27691	0.1170	IMPACT468	95	Adenocarcinoma	Yes	MSKCC	Nivolumab	2	0	No	NA	FALSE	NA	NA	PD1 alone	2019/08	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	13.28	Instable	1011552	34	LUAD	NA	NA	Cigars	YES	lung	27619	12.7	0:CENSORED	Lung	NA	FALSE	R144L	FALSE	NA	Tumor	1	648	Primary	Male	Former smoker	Matched	NA	Included	FALSE	NA	29.8	NA	SOC	No	2019, Wk. 34	NA